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The re-emergence of Cassava brown streak disease (CBSD) in the last twenty years is posing a huge 
threat to the cassava crop in sub-Saharan Africa with its rapid spread towards Western Africa, 
causing crop losses of up to 70% of the region’s second most important carbohydrate source. The 
causal agents of this disease were found to be Cassava brown streak virus (CBSV) and Ugandan 
cassava brown streak virus (UCBSV), with CBSV being the more virulent. The viruses were found to 
be the only two of the Ipomovirus genus to contain putative HAM1 pyrophosphatases with the 
function of the viral HAM1h proteins currently unknown. With breeding for resistant cassava 
cultivars not bringing much success in the field, discovery of the function of these unique proteins 
may provide a specific target for the development of resistance to CBSD.  
Work carried out in this thesis aimed to try to elucidate the function of the CBSV HAM1h. The viral 
HAM1 was first transformed into wild type and ham1 knockout yeast and used in spot assays against 
increasing concentrations of mutagens, to ascertain if the viral HAM1h does display the same 
phenotype as the overexpression of the yeast HAM1. Results from these show that the CBSV HAM1h 
does appear to have functionality. Secondly, the HAM1 transcript levels in Nicotiana benthamiana 
when infected with CBSV, were investigated to identify why the virus has its own HAM1, with results 
showing that the plant HAM1 is not downregulated upon CBSV infection. This suggests that the viral 
HAM1 acts against RNA non-canonical nucleotides and works in addition to the plant HAM1 to afford 
protection to high rates of mutagenesis. Further studies will need to be conducted to conclude if the 
CBSV HAM1h does display pyrophosphatase activity and whether this can be targeted to induce 
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CHAPTER 1 – INTRODUCTION 
 
1.1 FOOD SECURITY 
With the global population expected to reach 11.2 billion by the turn of the next century, the need for 
increased crop yields has never been more pressing (Johnson et al., 2017). It is estimated that 80% of 
the world’s population are currently malnourished and with the majority of those being in developing 
countries (von Braun, 2010; Abass et al., 2018), food production as it currently stands would have to 
be doubled by 2050 to accommodate for a rising population and ensure that everyone is adequately 
nourished (von Braun, 2010). Yet, with crop production yield increases reaching a plateau after the 
great advances made over the last sixty years (Johnson et al., 2017) and with approximately 25-40% 
of reduced crop production due to pests and pathogens (Myers et al., 2017), it is evident that crop 
cultivars resistant to pests and pathogens will be vital in the search for global food security (Johnson 
et al., 2017).  
Plant diseases have caused many famines globally that have devastated communities and indeed 
countries. One of the most well-known of these events is the Irish Potato Famine that occurred during 
the mid-nineteenth century when the oomycete pathogen, Phytophthora infestans, caused Potato 
late blight disease and decimated the crop causing famine across the whole country. As a result, 
almost one eighth of the population died and a further one million people emigrated. Such devastating 
losses were mainly accountable due to the fact that the population relied on one crop and that 
propagation of the monoculture was through the continued planting of apparently healthy tubers. 
The continued propagation of the tubers created a limited gene pool, making the crop highly 
vulnerable to new diseases, and thus the devastation of P. infestans infection was deemed inevitable 
(Scholthof, 2007).  
It is estimated that at least 10% of all global food crop production is lost due to plant disease alone, 
and with only fourteen crops providing the staple food source to diets worldwide (Strange and Scott, 
2005), understanding crop disease mechanisms is becoming imperative to ensure sufficient yields to 




 1.2.1 BACKGROUND 
Cassava (Manihot esculenta Crantz; Family Euphorbiaceae) is a woody perennial, growing to heights 
of between two and four metres (Fig. 1.1) (Pandey et al., 2000), and is farmed for its carbohydrate-
rich roots (Patil et al., 2015) across the tropical regions of Africa, Asia and Latin America (Patil et al., 
2011), where it provides food for an estimated 800 million people globally (Fondong, 2017; Wilson et 
al., 2017). Originating from Brazil where it has been cultivated for the past 9,000 years, its introduction 
into Africa in the sixteenth century following Portuguese conquests (Howeler et al., 2013; Fondong, 
2017) and with its expansion throughout the continent, the cassava crop is now Africa’s second most 
important food crop after maize (Abarshi et al., 2010). Subsequently, Africa is the largest producer of 
cassava globally (Abarshi et al., 2010), producing 158 million tonnes in 2013 (Bennet, 2015) and 
providing the staple food source for 67% of the poorer households in Eastern Uganda and Western 
Kenya alone (Taylor et al., 2012).  
 
Figure 1.1. View of the cassava crop in the field (reproduced from 
http://keralacultivation.blogspot.com/2010/12/tapioca.html) 
In Asia however, following on from its introduction in the eighteenth century (Pandey et al., 2000), 
the cassava crop is mainly used in industrial processes and as a promising source of biofuel, particularly 
from the cassava peels (Ye et al., 2017). Indonesia, the Philippines, Cambodia and East Timor all 
cultivate the crop for human consumption, while in Vietnam and China, large amounts of the cassava 
crop are used for animal feed, either for their own farms or as an export (Howeler, 2006). 
Intercropping of cassava is common in Asia where plots of land are small, to help increase yields of 
crops that are able to make use of the different nutrients available without exhausting them. Rice, 
maize, legumes and vegetables are all used in intercropping, with these planted in between rows of 
3 
 
cassava, and also provide the farmer with several crops over the year. Cassava can also be used as an 
intercrop itself for young trees like rubber and cashew. Very few economically important diseases 
affect the cassava crop in Asia, with the exception of the Indian sub-continent, so few steps need to 
be taken to reliably obtain a good yield (Howeler, 2006). The lack of precautionary methods taken to 
therefore ensure a broad gene pool, mean that the cassava crop may be particularly vulnerable if the 
diseases found in Africa are transmitted to Asia; with the crop being at risk of rapid decimation similar 
to what was seen when P. infestans caused the Irish Potato Famine.  
Cassava is particularly important in sub-Saharan Africa where the starchy roots comprise over half the 
calorie intake for more than fifty percent of the rural and urban populations in those countries 
(Abarshi et al., 2010). It is the continent’s second most important food staple in terms of the per capita 
calories consumed (Nweke, 2004; Tomlinson et al., 2017). Many subsistence farmers favour cassava 
production as the crop is tolerant to drought conditions, can be grown in marginal land and harvested 
throughout the year, is cheap to grow as it is propagated through stem cuttings (Abarshi et al., 2010), 
and can provide a high yield through its ability to grow large, starchy roots with little labour input 
(Wilson et al., 2017). These roots, which are high in carbohydrate content but low in protein and 
nutrient content (Wilson et al., 2017), form the primary carbohydrate source for the growers 
themselves and provide a source of income through the sale of the roots and the sale of flour 
processed from the roots (Olsen and Schaal, 1999; Tomlinson et al., 2017). Furthermore, as three 
quarters of the world’s ultra-poor (defined as living on less than fifty cents a day) are situated in sub-
Saharan Africa (von Braun, 2010), the cassava crop is vital to their survival and forms a huge part of 
the local economies. The cassava leaves are also a diet staple as they provide an important source of 
protein in several African countries (Lozano, 1986).  
Cassava has become a staple food security crop with its ability to remain in the ground for up to three 
years and produce harvest throughout the year and thus is able to outperform cereal crops which are 
quickly exhausted (Legg et al., 2014; Tomlinson et al., 2017). Cassava is certainly a suitable crop for 
the future with rising temperatures and extreme climatic events affecting the production of many 
cereal crops while cassava, on the other hand, is able to withstand these changing environmental 
conditions and high carbon dioxide concentrations. It has since become the second most important 
source of carbohydrate in sub-Saharan Africa, and over 105 counties are now recognising its 
advantages (Legg et al., 2014).   
 1.2.2 CASSAVA DISEASES 
Despite the high-yielding production, the cassava crop is affected by both biotic and abiotic factors 
that limit the yield of the starchy storage roots to fifteen tonnes per hectare worldwide as opposed to 
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a potential yield of fifty tonnes (Kuria et al., 2017). The ability of the plant to grow on malnourished 
soils is just one limiting factor to its productivity and in Asia, the use of irrigation in commercial settings 
has enabled productivity to quadruple (Blagbrough et al., 2010); a system that is not available to 
subsistence farmers in Africa.  
One of the limiting biotic factors is the crop’s susceptibility to disease; over thirty diseases, from 
bacterial to viral, are known to affect production (Owolade et al., 2005). Of these, cassava bacterial 
blight (CBB), caused by the bacterium Xanthomonas axonopodis pv. manihotis, devastated the crop in 
Africa and Latin America in the 1970s. It not only caused losses to the fresh roots of up to 75%, but 
also affected the protein-rich leaves, inducing losses of up to 80%. This disease was spread through 
the propagation of infected stem cuttings and then through the use of contaminated tools, as well as 
naturally through rain splashing (Lozano, 1986). Cassava anthracnose disease (CAD), furthermore, 
caused by the fungus Colletotrichum gloeosporioides f.sp. manihotis, induced widespread reductions 
in crop yield and extensive dieback across much of Africa, with 80-90% of cultivars showing high 
susceptibility, and was again spread through the propagation of infected stem cuttings as well as via 
the insect vector, Pseudotheraptus devastans. Both diseases were brought under control through the 
propagation of healthy cuttings, phytosanitation methods, and most successfully through the 
selection and breeding of resistant cultivars (Lozano, 1986; Fokunang et al., 2001; Owolade et al., 
2005; López and Bernal, 2012). Moreover, with the delay to the cassava planting season, CBB is now 
a disease of only minor importance (Lozano, 1986).  
There are at least twenty viral diseases (Patil and Fauquet, 2009) that can infect the cassava crop, with 
cassava mosaic disease (CMD) and cassava brown streak disease (CBSD) being the most devastating 
in Africa (Patil et al., 2011). Furthermore, the cultivation of the crop as a monoculture and the ease of 
planting of cassava from stem cuttings, forming its primary source of propagation, enables infection 
to persist and cause such devastating losses, as seen in Eastern Africa (Hillocks and Jennings, 2003).  
1.2.3 CASSAVA MOSAIC DISEASE 
  1.2.3.1 BACKGROUND 
Cassava mosaic disease (CMD) is caused by several cassava mosaic geminiviruses (Family 
Geminiviridae; Genus Begomovirus) and is widespread throughout Africa and the Indian subcontinent 
(Patil and Fauquet, 2009; Vanderschuren et al., 2009). Cassava mosaic geminiviruses consist of two 
circular single-stranded DNA parts, DNA A and DNA B. DNA A constitutes the viral coat protein (AV1), 
a silencing suppressor that targets the post-transcriptional gene-silencing response of the plant (AV2), 
suppressors of host-mediated gene silencing (AC2 and AC4) and viral replication genes (AC1 and AC3). 
5 
 
DNA B on the other hand, encodes two genes that are involved with the movement of the virus within 
the host (BC1 and BV1) (Singh et al., 2015; Kuria et al., 2017).  
There are eleven recognised species of cassava mosaic geminiviruses and the disease is transmitted 
by the whitefly Bemisia tabaci on a persistent basis, as well as through the propagation of infected 
stem cuttings (McCallum et al., 2017). CMD, having first been described in Tanzania in 1894, is now 
found in all cassava-cultivating countries of Africa (Hillocks and Thresh, 2000; Legg et al., 2014) and is 
responsible for not only economic losses of between 1.9 and 2.7 billion US Dollars annually, but also 
for the loss of millions of lives as a result of malnutrition following the disease pandemic in Central 
and Eastern Africa (Scholthof et al., 2011).  
Symptoms of CMD are characterised by the chlorotic mosaic patterning on leaves, deformed leaves 
and the stunting of shoot growth (McCallum et al., 2017). Not only does this disease severely affect 
the cassava crop foliage, which is also consumed as it provides a source of protein (Howeler et al., 
2013), it also affects the root tuber yield causing average losses of 82% (McCallum et al., 2017) but 
with some highly susceptible cassava varieties experiencing 100% losses in root yield (Fondong, 2017).  
  1.2.3.2 RESISTANCE TO CMD 
Some protection has been afforded against CMD through the breeding of naturally resistant cassava 
varieties and through the planting of healthy stem cuttings. In countries such as the Democratic 
Republic of Congo, where the leaves are consumed as nutritious vegetables, there has been selection 
for cassava cultivars showing mild foliar CMD symptoms, instead of those expressing no symptoms. 
This has hindered some of the control of CMD through the planting of CMD-susceptible varieties 
(Thresh and Cooter, 2005), yet the use of CMD-resistant varieties has successfully been used to control 
devastating epidemics in Madagascar, Nigeria and Uganda (Thresh and Cooter, 2005). Work over the 
years has shown that the planting of virus-free cuttings, the use of improved resistant varieties and 
the wide-spread use of phytosanitation methods, can effectively control CMD across large areas 
(Thresh and Cooter, 2005). There are currently three types of CMD resistant cassava strategies that 
have been deployed for use in the field. The first (CMD1) was introgressed from Manihot glaziovii 
Muell. Arg. (ceara rubber) but is recessive and polygenic. The second (CMD2) is derived from a single 
genetic locus and is found in various strains of West African Manihot esculenta landraces. This form 
of resistance is highly heritable and is also able to confer stable resistance to a broad spectrum of 
cassava mosaic geminiviruses, and thus has been used in breeding programmes in Africa and Latin 
America to produce highly CMD resistant cultivars. The third cultivar (CMD3) is highly resistant to 
CMD, with less than 1% disease incidence, and contains the same genetic locus as the second resistant 
cultivar, but also another locus in the same linkage group (Kuria et al., 2017). A recent study by Beyene 
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et al. (2016) showed that field level CMD2 resistance may be at threat, however, with the regeneration 
of plants through somatic embryogenesis showing susceptibility to CMD in field trials. Furthermore, 
this generation and wide-spread distribution of CMD-resistant cassava varieties across much of Africa 
may have helped spread CBSD as many of these cultivars show susceptibility to the disease 
(Vanderschuren et al., 2012).  
With no known cultivars conferring resistance to both CMD and CBSD to date, the objective remains 
to generate a cultivar that is tolerant to the two diseases. Following advances in sequencing and 
biotechnology, work has been done on antiviral RNA silencing associated defence mechanisms, with 
the loss of cassava mosaic virus RNA from infected plants having been seen (Kuria et al., 2017). In the 
years to come, this could provide a promising source of resistance that could also incorporate 
resistance to CBSD.  
1.3 CASSAVA BROWN STREAK DISEASE 
 1.3.1 HISTORY OF THE DISEASE  
Cassava brown streak disease (CBSD) was first described in 1936 in the Amani district of Tanzania 
(Storey, 1936) and by 1950 was found in the lowlands (less than 1000 metres above sea level) along 
the East African coast from Mozambique to Kenya and inland to include the lowlands of Malawi and 
Uganda (Nichols, 1950; Mbanzibwa et al., 2009a). This first discovery of CBSD identified symptoms on 
the lower leaves and rot of the tuber roots (Storey, 1936). It wasn’t until a study by Nichols in 1950 
that the observation that the disease can affect all parts of the plant, was made. Subsequently, two 
main foliar symptoms of CBSD have been described: firstly, the feathery chlorosis along secondary 
veins, and secondly, mottled chlorosis that appears distinct to the feathering along the veins (Nichols, 
1950; Tomlinson et al., 2017). Nichols (1950) also discovered that the severity of symptoms can vary 
on biotic factors, such as the cultivar and age of the cassava plant when infected, and on abiotic factors 
such as the environmental conditions. Moreover, the symptoms and severity of the disease are 
affected by the viral strain (Nichols, 1950), with many isolates having since been identified (Monger 
et al., 2001b). These differences in symptom severity, ranging from those plants exhibiting severe 
foliar and root symptoms, to severe root necrosis and only mild leaf chlorosis or vice versa, to those 
exhibiting both mild leaf and root symptoms, make detection of CBSD in the field extremely difficult 
(Kaweesi et al., 2014). Most farmers are thus unaware that the crop is infected until they come to 
harvest the root tubers (Legg et al., 2015). The initial spread of CBSD along the lowlands of the East 
African coast and inland, furthermore, is thought to have been through the planting of infected stem 
cuttings from the Amani district, particularly with the spread of the disease to Uganda (Nichols, 1950; 
Jameson, 1964; Tomlinson et al., 2017). The spread of infection further afield was prevented through 
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the lack of observation of any vector-borne transmission at higher altitudes (Nichols, 1950; Jennings, 
1960; Tomlinson et al., 2017), keeping this disease confined to the lowland regions of East Africa for 
the next seventy years (Mbanzibwa et al., 2009a).  
 1.3.2 INITIAL METHODS TO CONTROL CBSD 
As a consequence of the spread of CBSD, mechanisms of control were established. Initial breeding of 
cultivated cassava varieties with wild relatives, such as Manihot glaziovii, M. dichotoma, M. catingea, 
M. saxicola and M. melanobasis, all species which showed greater resistance to CBSD, began in 1937 
with the view to creating tolerant cultivars (Jennings, 1957; Nichols, 1946; Kawuki et al., 2016; 
Tomlinson et al., 2017). Tolerance for CBSD is defined as those cassava varieties displaying no root 
necrosis or those displaying root rot at a late stage of growth (Legg et al., 2011). Hybrids generated 
from this cross-breeding programme that were subsequently introduced to the local farmers included 
the first cassava cultivar to be produced which showed relatively high levels of tolerance to CBSD 
(Kaweesi et al., 2014; Tomlinson et al., 2017). This CBSD tolerant cultivar was the M. esculenta-M. 
glaziovii hybrid, known as ‘Namikonga’ in Tanzania and ‘Kaleso’ in Kenya, but it was not widely 
distributed to farmers due to its susceptibility to CMD (Hillocks and Jennings, 2003; Kaweesi et al., 
2014; Tomlinson et al., 2017).  
Following on from the increase in CBSD incidence observed in the 1990s along East Africa, virus-free 
tolerant CBSD cultivars were made available to farmers in Mozambique who relied heavily on CBSD 
susceptible cassava plants (Hillocks and Jennings, 2003; Tomlinson et al., 2017). At this time, CMD was 
the more devastating disease, causing wide-spread famine across Africa with many farmers 
abandoning the crop, and so methods to control and prevent the spread of CBSD were of little 
importance as it seemed to remain confined to the lowlands of East Africa (Thresh and Cooter, 2005; 
Tomlinson et al., 2017). As a result, CMD resistant cultivars were widely distributed amongst farmers 
(Legg and Thresh, 2000; Tomlinson et al., 2017), but as these varieties show varying levels of 
susceptibility to CBSD, it is thought this may have helped spread CBSD (Legg et al., 2006; Tomlinson et 
al., 2017). The development of CBSD resistant cultivars through traditional breeding methods has 
proved difficult and is limited by the availability of resistance genes to the causal viruses in existing 
cassava varieties (Taylor et al., 2016), but cultivars created from the initial breeding programme 
started in 1937 still form an important genepool for the continued search for CBSD resistance (Kaweesi 
et al., 2014).  
 1.3.3 RE-EMERGENCE OF CBSD 
In late 2004, incidences of CBSD were observed in central Uganda, and marked the first time it had 
been seen in Uganda since the initial introduction of the disease from Tanzania in the 1940s (Alicai et 
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al., 2007). Moreover, this re-emergence of CBSD was now found at higher altitudes, over 1000 metres 
above sea level, and over 1000km inland. No longer was CBSD restricted to the lowlands of coastal 
East Africa and the surrounding lowlands of Lake Malawi, but the disease was now spreading 
westwards to Central Africa (Fig. 1.2). The current CBSD epidemic in East Africa is responsible for most 
of the cassava losses and it is feared with its increasing spread of infection, the disease will reach the 
cassava-producing countries in Central and West Africa, which are some of the world’s leading, and 
where CBSD is currently not found. CBSD has already spread to neighbouring Rwanda, Burundi, The 
Democratic Republic of Congo, South Sudan and even on into Congo (Alicai et al., 2007; 2016; Legg et 
al., 2014; Patil et al., 2015).  
 
Figure 1.2. Map showing the spread of CBSD in the 1930s, with the two viral species being found in separate and 
overlapping areas, and the re-emergence of the disease in 2004 (reproduced from Legg et al., 2015). 
This new incidence of CBSD in Central Uganda is thought to either have arisen from a new introduction 
of the disease from the planting of infected stem cuttings, or that the disease had persisted, albeit at 
low levels, from its initial introduction in the 1940s (Alicai et al., 2007; Tomlinson et al., 2017). 
Confirmation of the disease was carried out using RT-PCR from plants displaying CBSD symptoms at 
these higher altitudes in Uganda (Alicai et al., 2007). Comparison of the coat protein sequence from 
this viral isolate to those from CBSD-infected plants in Mozambique and Tanzania, revealed only 77.0 
to 82.9% sequence identity (Alicai et al., 2007; Tomlinson et al., 2017) suggesting that two genetically 
different viral strains cause CBSD (Mbanzibwa et al., 2009a).  
Initial studies thought that the causal agent was a member of the carlaviruses, based on the particle 
size of around 650nm and its flexuous rod shape, but the discovery of pin wheel inclusion bodies made 
it typical of a potyvirus infection (Lennon et al., 1985; Legg et al., 2015). Furthermore, raising an 
antiserum to the Cowpea mild mottle virus (family: Betaflexiviridae, genus: Carlavirus) in cassava 
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plants revealed that this virus was not the causal agent of CBSD (Lennon et al., 1985; Legg et al., 2015). 
It was not until 2001 when work by Monger et al. (2001a) demonstrated that a virus consistently 
associated with CBSD showed similarities to members of the genus Ipomovirus within the Potyviridae 
family, with its coat protein showing 43.2% sequence identity to that of Sweet potato mild mottle virus 
(SPMMV), the then only sequenced virus belonging to the Ipomovirus genus. Further work by Monger 
et al. (2001b) comparing coat protein sequences between isolates from Mozambique and Tanzania, 
varying by 8% and 6% at the nucleotide and amino acid levels respectively, revealed that there may 
be several different strains of CBSD-causing viruses, with the appearance of variable symptoms on 
different cassava cultivars (Hillocks et al., 1996; Monger et al., 2001b) and experimental hosts, such 
as Nicotiana benthamiana (Monger et al., 2001b), also supporting this observation (Legg et al., 2015).  
It was confirmed that CBSD is caused by two phylogenetically related species of positive-sense single-
stranded RNA viruses belonging to the genus Ipomovirus in the Potyviridae family (Mbanzibwa et al., 
2009b; Winter et al., 2010; Patil et al., 2011). Symptoms on cassava plants from Uganda varied to 
those grown in different environmental conditions in the coastal, lowland regions of Tanzania and 
Mozambique, and subsequent sequence analysis of the isolated viral fragments revealed on average 
only approximately 70% nucleotide homology and 74% polypeptide homology, thus confirming the 
appearance of two distinct species (Mbanzibwa et al., 2009a; 2011a; Monger et al., 2010; Winter et 
al., 2010). Cassava brown streak virus (CBSV) was responsible for the first CBSD infection in the 
lowland and coastal regions of East Africa, and Ugandan cassava brown streak virus (UCBSV) was 
responsible for the spread of infection to highland regions and the Lake Victoria basin (Patil et al., 
2011), though both species are now found across the highlands and lowlands of this East African 
region (Fig. 1.2), where co-infection of CBSV and UCBSV is not uncommon (Ndunguru et al., 2015). 
Indeed, this co-infection now forms 34-50% of CBSD cases in Kenya (Kathurima et al., 2016), Tanzania 
(Mbanzibwa et al., 2011b) and Uganda (Ogwok et al., 2014; Tomlinson et al., 2017). Whether the two 
viruses act synergistically in the cassava hosts is still unknown (Tomlinson et al., 2017), though 
Vanderschuren et al. (2012) did not find any evidence of such in the field.   
 1.3.4 DETECTION AND PROPAGATION OF CBSD 
Detection of CBSD infection above ground is near impossible with new growth and immature leaves 
showing no symptoms (Fig. 1.3.A), and with the infection symptoms varying with the cassava cultivar 
and the environmental conditions (Nichols, 1950; Monger et al., 2001b). The study by Mohammed et 
al. (2012) has highlighted the differences in symptom severity on various cassava varieties, with the 
variety Albert showing high susceptibility to both CBSV and UCBSV, with other varieties showing 
greater susceptibility to CBSV only. Most symptoms are present in the older leaves where oxidative 
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stress becomes the main driving force of causing early senescence in the cassava crop (Mbanzibwa et 
al., 2009b) with the crop then exhibiting the tendency to shed these older symptomatic leaves, 
especially during long dry periods, making detection of the infection even less obvious (Monger et al., 
2001a; Abarshi et al., 2010). Foliar chlorotic symptoms only become visible as the leaf matures as 
opposed to when the leaf unfurls, as is observed in cassava infected with CMD, and the chlorosis 
differs from CMD in that it appears as feathering along the veins (Fig. 1.3.B). With CBSD, there is also 
a lack of leaf distortion and furthermore, the symptoms of CBSD can often be masked by other 
diseases, such as CMD, or by pests like the cassava green mite (Mononychellus tanajoa) (Abarshi, et 
al., 2010). CBSD can be detected in all parts of the cassava plant, however, whether exhibiting 
symptoms or not (Abarshi et al., 2010), and an RT-PCR test has been developed that can detect the 
virus even in the young cassava leaves that are not yet showing symptoms (Monger et al., 2001b). Use 
of this RT-PCR test has also been used to demonstrate that virus titre is lowest in the young leaves, 
















Figure 1.3. A. Cassava infected with CBSV (variety Kibandameno) with leaves from positions top (T), middle (X) and bottom 
(B) of plant showing symptom severity increasing with maturity of leaves. B. H-1 and H-2 were asymptomatic for CBSV 
whilst C-1 and C-2 show the foliar chlorosis symptoms of CBSV (variety Kibandameno) (reproduced from Saggaf et al., 
2018). 
The characteristic feature of CBSD infection which gives the disease its name, is the brown, streaky 
lesions that can be found on the stems beneath the bark and which appear as purple or brown lesions 
on the exterior of young stems (Fig. 1.4). Despite this being the characteristic feature of the disease, 
however, it is not always present (Hillocks and Jennings, 2003). Outbreaks of CBSD were found to 
occur around three to twelve years after increases in whitefly numbers, with these whiteflies also 
being able to thrive above 1000 metres above sea level (Alicai et al., 2007; Legg et al., 2011; Tomlinson 
et al., 2017). It was confirmed that CBSD is also transmitted by whitefly vectors, with Bemisia afer 





transmits CBSD (Maruthi et al., 2005). Spread of CBSD infection through the insect vector is only semi-
persistent, with infection being spread by B. tabaci approximately 22% of the time, as has been 
observed in the field and in laboratory conditions by Maruthi et al. (2005). This suggests that the 
disease is spread further afield by the whitefly vector, but that the disease persists through the 
propagation of asymptomatic infected stem cuttings (Patil et al., 2011; Yadav et al., 2011; Tomlinson 
et al., 2017).  
 
Figure 1.4. Brown streaks observed on the stems of the cassava plant (reproduced from Patil et al., 2015). 
 1.3.5 ECONOMIC IMPACT 
The spread of CBSD at such a pace is concerning as this disease has up to 100% incidence and in the 
most severe cases, can cause decreases of up to 70% in root weight (Hillocks et al., 2001; Maruthi et 
al., 2005; Ateka et al., 2017). It is considered to be more of a threat than CMD as not only does it cause 
a reduction in overall yield (Fig. 1.5.A), but CBSD causes the dry, necrotic rot of the root tubers (Fig. 
1.5.B) which appears around six months post planting, and renders them unfit for human consumption 
and for sale (Hillocks et al., 2001; Maruthi et al., 2005; Patil, et al., 2011; Mohammed et al., 2012), 
severely affecting those that rely on this staple crop. Furthermore, the extent of the damage to the 
roots caused by CBSD does not become apparent until they are harvested (Maruthi et al., 2005), where 
they subsequently suffer rapid deterioration (Monger et al., 2001a). As a result, farmers suffer further 
reduced yields through the premature harvesting of the crop before the root necrosis takes hold 




Figure 1.5. A. Constrictions on the root surface of cassava which reduce the root yield. B. The dry, necrotic rot of the 
cassava root (reproduced from Patil et al., 2015). 
 1.3.6 CBSV AND UCBSV 
Advances in sequencing technology have enabled more isolates of CBSV and UCBSV to be identified 
and sequenced. Complete genome analysis of CBSV and UCBSV isolates have revealed that the UCBSV 
genome is larger, with a length of 9,069 nucleotides for its MLB3 isolate, compared to that of the CBSV 
isolate TZ: Kor6: 08, which is 8,995 nucleotides in length (Ndunguru et al., 2015). Analysis also showed 
that genetic diversity is greater among the CBSV isolates, with 79.3-95.5% sequence identity, 
compared to the UCBSV isolates which show 86.3-99.3% sequence identity (Ndunguru et al., 2015). 
Indeed, these differences in isolate identity have suggested that there may be more than two species 
causing CBSD, with CBSV and UCBSV forming two clades, with the potential of three species within 
the UCBSV clade alone (Fig. 1.6) (Ndunguru et al., 2015; Tomlinson et al., 2017).  
 
Figure 1.6. Phylogenetic tree of the full genome sequences of isolates of CBSV and UCBSV, highlighting how there is the 
potential for species within the CBSV and UCBSV clades (reproduced from Patil et al., 2015). 
Differences in genome sequence may be behind the variability in symptom severity caused by CBSV 
and UCBSV. Cassava plants infected with CBSV suffer from more severe root necrosis and foliar 
symptoms coalesce to form chlorotic blotches on the leaves, whereas with UCBSV infection, both 




plants (Kaweesi et al., 2014) and indicator plant hosts (Mohammed et al., 2012) compared to 
infections with UCBSV, demonstrating that CBSV is the more virulent of the two (Ndunguru et al., 
2015; Tomlinson et al., 2017). The greater diversity of CBSV isolates may also be the reason why 
resistant cassava cultivars are hard to generate as the viral isolates can rapidly adapt to outsmart the 
plant defence mechanisms that are selected for (Tomlinson et al., 2017).  
1.4 FAMILY – POTYVIRIDAE 
 1.4.1 BACKGROUND 
With at least 176 species currently described, the Potyviridae is the largest viral plant pathogen family 
and contains many viral diseases that cause catastrophic losses both economically and agriculturally. 
The family comprises eight genera: Brambyvirus, Bymovirus, Ipomovirus, Macluravirus, Poacevirus, 
Rymovirus, Tritimovirus and Potyvirus, which is the largest genus. Viruses belonging to the Potyviridae 
family have single-stranded RNA genomes that are encapsulated in flexuous filamentous particles of 
length 650-900nm. The genera are further categorised based on their vector transmission and 
genomic relatedness as shown in Table 1.1 (Adams et al., 2005a; 2005b; Dombrovsky et al., 2014).  
Table 1.1. Table of the different genera belonging to the Potyviridae family showing their genome organisation and methods 
of vector transmission (Adams et al., 2005a; 2005b; Dombrovsky et al., 2014). 
Genus Number of Species Genomic Organisation Transmission Vector 
and Manner 
Potyvirus 146 Monopartite Aphids 
Non-persistent 
Ipomovirus 6 Monopartite Whiteflies 
Semi-persistent 
Macluravirus 6 Monopartite Aphids 
Non-persistent 
Poacevirus 2 Monopartite Mites 
Rymovirus 3 Monopartite Eriophyid 
Abacarus mites 
Semi-persistent 
Tritimovirus 5 Monopartite Eriophyid Aceria mites 
Semi-persistent 
Brambyvirus 1 Monopartite - 








 1.4.2 GENOME ORGANISATION 
With the exception of viruses belonging to the Bymovirus genus, the genomes of viruses within the 
Potyviridae family encode a large polyprotein that is cut by three virus-encoded proteases to form ten 
mature proteins: P1, HC-Pro, P3, 6K1, CI, 6K2, VPg, NIa-Pro, NIb and CP (Adams et al., 2005b). This 
genome organisation is highly conserved amongst the family (Fig. 1.7). In the case of the Bymovirus 
genus, however, which has a bipartite genomic construction, RNA1 encodes eight of the proteins 
found in the other genera viral genomes from P3 onwards, and the smaller RNA2 part of the Bymovirus 
genome, which has less similarity to the 5’-section of the other genera in the family, the C-terminal of 
the Bymovirus P2-1 gene resembles the C-terminal part of the helper component proteinase (HC-Pro) 
gene found in the monopartite viruses (Adams et al., 2005a; 2005b). All members of the Potyviridae 
family are characterised by the production of pinwheel-shaped crystalline cylindrical inclusion bodies 
in the cytoplasm of infected cells, encoded by the viral CI protein, with these pinwheel-shaped 
inclusion bodies having been found in CBSD infected plants (Mbanzibwa et al., 2009a).  
 
Figure 1.7. Comparison of the viral genomes of four genera of the family Potyviridae: Potyvirus – Potato virus Y (PVY), 
Rymovirus – Ryegrass mosaic virus (RGMV), Tritimovirus – Wheat streak mosaic virus (WSMV) and Ipomovirus – Sweet 
potato mild mottle virus (SPMMV). Further comparison between the genome structures of members of the Ipomovirus 
genus are shown, with Squash vein yellowing virus (SqVYV), Cucumber vein yellowing virus (CVYV) and Cassava brown 
streak virus (CBSV). Numbers indicate the estimated relative molecular weights of the proteins (kDa) (reproduced from 






1.5 GENUS – IPOMOVIRUS 
Ipomoviruses are transmitted by whiteflies and despite there only being six viral species within this 
genus, they are able to infect a range of plants from four families; from sweet potato (Ipomoea 
batatas, Family: Convolvulaceae), watermelon (Citrullus lanatus, Family: Cucurbitaceae), cucumber 
(Cucumis sativus, Family: Cucurbitaceae), squash (Family: Cucurbitaceae), tomato (Solanum 
lycopersicum, Family: Solanaceae) to cassava (M. esculenta Crantz Family: Euphorbiaceae), and cause 
serious losses to those crops. The single-stranded positive-sense RNA genomes of the Ipomovirus 
genus range in size from 9,069 nucleotides in length to 10,818 for CBSV and Squash vein yellowing 
virus (SqVYV) respectively. Like the rest of the Potyviridae family, Ipomovirus genomes encode a 
singular open reading frame (ORF) with the addition of a small protein known as PIPO that is produced 
occasionally when frameshift allows for the expression of a short overlapping ORF within the encoded 
P3 protein (Mbanzibwa et al., 2009b; 2011a; Dombrovsky et al., 2014). Coat protein (CP) sequence 
analysis of CBSV revealed that it shared 43.2% homology with the CP sequence of isolates of Sweet 
potato mild mottle virus (SPMMV), the type species of the Ipomovirus genus, confirming the virus’ 
status in the genus (Monger et al., 2001a; Mbanzibwa et al., 2009a; 2011a).  
Ipomoviruses are highly variable in the protein-encoding 5’ region of their genomes (Fig.1.8) where 
the genus can be split into three groups depending on the presence and structure of the P1 and HC-
Pro proteins. Only SPMMV and Tomato mild mottle virus (TomMMoV) contain the HC-Pro protein, 
which usually acts as a suppressor of RNA silencing-mediated host defence among other functions in 
other Potyviridae members (Webster and Adkins, 2012), and a P1 proteinase which is an enhancer of 
the HC-Pro RNA silencing suppressor activity (Webster and Adkins, 2012). Where this P1 protein is 
lacking in the SqVYV and Cucumber vein yellowing virus (CVYV) genomes, its role is instead covered by 
a second P1 proteinase, P1b, though its mode of action is significantly different to that of the P1 of 
SPMMV (Valli et al., 2008; Giner et al., 2010; Webster and Adkins, 2012). In the CBSV and UCBSV 
genomes, however, the HC-Pro protein is not present and nor are there the two P1 proteinases. These 
two viruses are thus the first members of the Potyviridae family to encode a single P1 proteinase and 
no HC-Pro (Mbanzibwa et al., 2009b). Sequence analysis by Mbanzibwa et al. (2009b) revealed that 
the P1 of CBSV is most closely related to the P1 of SPMMV and the P1b proteins of SqVYV and CVYV. 
Despite the CBSV P1 protein only showing sequence identity of 31 and 30% to the P1b proteins of 
CVYV and SqVYV respectively, the conserved histidine, aspartic acid and serine motif in the HDS triad 
of the P1 protein was observed in the CBSV genome, suggesting that the P1 protein of CBSV also 
functions as a suppressor of RNA silencing (Mbanzibwa et al., 2009b; 2011a). It is thought that the 
high variability in structure at the 5’-end of Ipomovirus genomes implies that recombination has been 
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vital to the P1 evolution and has aided in the facilitation of the viruses to adapt to a wide range of 
hosts (Valli et al., 2007; Mbanzibwa, et al., 2009b; 2011a; Dombrovsky et al., 2014). 
Figure 1.8. Diagram showing the different genomic structures of the viruses belong to the Ipomovirus genus and how they 
can be separated into three groups based on the genomic organisation (reproduced from Dombrovsky et al., 2014). 
 
1.6 CBSV AND UCBSV VIRAL PROTEINS 
The Ipomovirus RNA genomes are translated as polyproteins and then cleaved by the encoded 
proteases to form ten mature proteins (Mbanzibwa et al., 2011a). The following descriptions of the 
proteins and their functions are based on those belonging to other viruses in the Potyviridae family 
that have been studied and outlined, but the functions of the proteins found in the CBSV and UCBSV 
genomes are likely to be similar.  
 1.6.1 P1 PROTEIN 
The P1 protein, the most variable part of the genome, is a serine protease that cleaves itself from the 
polyprotein at its C-terminus to function in trans to stimulate genome amplification, with it also being 
shown that in vitro, the P1 proteinase can interact with nucleic acids (Adams et al., 2005a; 2005b; 
Dombrovsky et al., 2014; Revers and García, 2015). It also functions as a suppressor to RNA silencing, 
enhancing the action of HC-Pro, but the function of P1 is dependent on its separation from HC-Pro 
(Valli et al., 2006; Mbanzibwa et al., 2009b; Revers and García, 2015). The P1 protein is the most 
divergent potyviral protein due to large variability in its N-terminal region and subsequently, 
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negatively regulates P1 self-cleavage (Adams et al, 2005a; Valli et al., 2007; Pasin et al., 2014; Revers 
and García, 2015). Where the P1 protein is not present, two evolutionary diversified proteins exist in 
the genomes of SqVYV and CVYV, P1a and P1b (Carbonell et al., 2012; Tatinemi et al., 2012).  
  1.6.1.1 P1A 
Sequence identity analysis has revealed that the P1a proteins of SqVYV and CVYV show high identity 
with the P1 proteins of the aphid transmitted potyviruses (Webster and Adkins, 2012), suggesting that 
this protein may function in the viral interactions with the insect vector.  
  1.6.1.2 P1B 
Sequence analysis has shown that the P1b proteins of SqVYV and CVYV show they are more related to 
the P1 proteins of Tritimoviruses (Webster and Adkins, 2012), and as described in 1.4, function as 
suppressors to RNA silencing.  
 1.6.2 HELPER COMPONENT PROTEINASE (HC-PRO) 
The HC-Pro is a multifunctional protein with its name deriving from its first discovered function as the 
Helper Component (HC) for aphid transmission (Govier et al., 1977; Revers and García, 2015). It is a 
cysteine protease that, like P1, cleaves itself at its C-terminus (Revers and García, 2015). The protein 
can be divided into three regions: the N-terminal (approximately 100 amino acids), the central region 
(approximately 250 amino acids) and the C-terminal (approximately 100 amino acids). The N-terminal 
is responsible for functions involving aphid transmission and the C-terminal contains the protease 
activity that allows for the self-cleavage at the C-terminus (Dombrovsky et al., 2014; Revers and 
García, 2015). Two domains, domain A and domain B, have been found in the central region of the 
protein which independently bind RNA and where most of the protein functions are based. Domain B 
contains highly conserved motifs that are implicated in RNA amplification and the systemic movement 
of the virus, with mutations of these motifs preventing such actions (Cronin et al., 1995; Urcuqui-
Inchima et al., 2001; Revers and García, 2015). Along with its role of suppressing RNA silencing, 
enhanced by the P1 protein (Valli et al., 2006), the HC-Pro is required to stabilise the viral coat protein, 
increase viral titre and ensure the infectivity of viral progeny (Revers and García, 2015).  
 1.6.3 P3 PROTEIN 
Little is still known about the mechanisms behind the function of the P3 protein, however, it is known 
that this protein is required for viral replication. The P3 protein does not seem to bind with viral RNA, 
but instead targets the membrane of the endoplasmic reticulum and forms inclusions associated with 
the Golgi apparatus. The P3 protein has also been found to associate with the pinwheel-shaped 
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inclusion bodies produced by the viral CI protein that are characteristic of the Potyviruses (Revers and 
García, 2015).  
  1.6.3.1 PIPO 
PIPO is formed through the plus two frameshift of an overlapping ORF within the P3 gene sequence. 
The P3N-PIPO complex is a 25kDa protein that appears to play a role in viral cell-to-cell movement 
through association with the CI protein. The P3N-PIPO and CI proteins are transported to the 
plasmodesmata via the secretory pathway, where they coordinate to form conical structures that 
associate with the plasmodesmata to facilitate viral intercellular movement. Furthermore, CI 
mutations that impair the ability of the protein to associate with plasmodesmata, have prevented viral 
intercellular movement (Wei et al., 2010; Revers and García, 2015).  
 1.6.4 6K1 AND 6K2 PROTEINS 
6K1 and 6K2 are small proteins, both only 52 amino acids long and each weighing 6kDa, and like the 
P3 protein, they do not bind to any viral RNA (Mbanzibwa et al., 2009b; Revers and García, 2015). 6K1 
is hypothesised to be involved in viral infectivity and that the combination of P3-6K1 and its 
subsequent proteolytic process, may have a regulatory role specifically for the multiplication of the 
potyvirus (Revers and García, 2015).  
The 6K2 protein, when a part of the 6K2-VPg-NIaPro complex, plays a crucial role in viral RNA 
replication (Revers and García, 2015).    
 1.6.5 CYLINDRICAL INCLUSION PROTEIN (CI) 
The CI protein is responsible for forming the characteristic pinwheel-shaped inclusion bodies of 
Potyviral infection. The CI protein is also responsible in viral replication by providing ATPase and RNA 
helicase activities and plays an important role in viral cell-to-cell movement. The CI protein associates 
with the P3N-PIPO complex to aid viral movement, though the mechanism is not yet known. The CI 
protein also binds to the end of the viral genome where it is thought to provide a motor function to 
facilitate viral movement through the plasmodesmata (Revers and García, 2015).  
1.6.6 NUCLEAR INCLUSION PROTEIN (NIA) 
The NIa is the largest protein found in Ipomovirus genomes and forms a crystalline inclusion in the 
host, most commonly in the nucleus but they can also appear in the cytoplasm of infected host cells.  
NIa in its whole form can bind to the 5’-end of the Ipomovirus genome, localising both in the cytoplasm 
and the nucleus, and exhibits NTPase activity. The function of this NTPase activity is still unknown 
(Revers and García, 2015).  
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The protein NIa can also be cleaved to produce two proteins: VPg at the amino (N) terminus and 
NIaPro at the carboxy (C) terminus. Cleaving is quite inefficient and so implies that both intact NIa 
protein and the processed VPg and NIaPro proteins coexist in the infected cells (Martínez et al., 2016).   
1.6.6.1 VIRAL GENOME-LINKED PROTEIN (VPG) 
The VPg protein is able to interact with many different proteins, including itself, and thus is involved 
in many processes including viral replication, translation and movement (Revers and García, 2015; 
Martínez et al., 2016). The VPg protein on its own, forms a covalent link with the 5’-end of the 
Ipomovirus genome by means of a Tyr residue and consequently binds a host translation initiation 
factor that is required for infection (Martínez et al., 2016). When the VPg protein forms part of the 
6K2-VPg-NIaPro complex, it instead targets viral membranous factories where it plays a vital role in 
viral RNA replication. There has also been evidence that VPg could undergo phosphorylation and this 
post-translational modification could provide the regulation for the various roles this protein is 
involved in (Revers and García, 2015).   
1.6.6.2 NIAPRO 
NIaPro is a serine protease that cleaves itself from the remainder of the viral polyprotein before 
cleaving the viral polyprotein in both the cis and trans directions at specific conserved motifs to 
generate most of the viral proteins. It also exhibits RNA binding associating with the NIb protein, the 
viral RNA-dependent RNA polymerase, and is involved in viral replication (Martínez et al., 2016). 
Furthermore, NIaPro provides DNase activity and it is thought that when the NIa protein is in the host 
nucleus, this could provide some regulation in host gene expression which is beneficial for the viral 
infection (Revers and García, 2015).  
1.6.7 NUCLEAR INCLUSION PROTEIN B (NIB) 
The NIb protein is the RNA-dependent RNA polymerase that is crucial for the replication of the viral 
genome. NIb interacts with VPg and NIaPro as part of the VPg-6K2-NIaPro complex on membranous 
structures where it uridylylates VPg to prime for viral RNA synthesis and start the process of viral 
replication. Further interaction of the NIb protein with selected host proteins, allows for the creation 
of replication complexes contributing to the process of the viral RNA replication. NIb also forms 
nuclear inclusion bodies with the NIa protein where it is thought that a possible interaction with a host 
enzyme may bring about the regulation of NIb activity in the nucleus while also allowing NIb to make 
the environment in the cell more favourable for viral replication, although the role that the NIb protein 
plays in the nucleus is still largely unknown (Revers and García, 2015).  
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 1.6.8 HAM1H PROTEIN 
The presence of a 226 amino acid sequence, the HAM1 homologue (HAM1h), between the viral 
replicase (NIb) and coat protein (CP) in the CBSV and UCBSV genomes is unique among the Ipomovirus 
genus. Only one other virus is known to contain a HAM1h protein and that is the Euphorbia ringspot 
virus (EuRSV). Despite this virus also infecting a Euphorbiacea plant, EuRSV, however, belongs to the 
Potyvirus genus. The HAM1h proteins found in these viral species are homologous to the Maf/HAM1 
superfamily found in prokaryotes and eukaryotes where these proteins function as nucleoside 
triphosphate pyrophosphatases (NTPases), reducing the rates of mutation during nucleic acid 
replication by hydrolysing non-canonical bases in nucleotide precursor pools. The HAM1h function in 
these viruses remains unknown, but it is suggested they function in reducing mutation rates of the 
viral RNA (Monger et al., 2010; Mbanzibwa et al., 2011a).  
 1.6.9 COAT PROTEIN (CP) 
The coat protein’s primary role is to encapsulate the viral genome with around 2,000 helical subunits 
required to enclose the Potyviral RNA. The coat protein also functions in aphid transmission, viral 
assembly and viral cell-to-cell movement (Revers and García, 2015; Urcuqui-Inchima et al., 2001). The 
central region of Potyvirus coat proteins is highly conserved while the N- terminal is highly variable 
and the C- terminal variable, and it is these terminals that interact together in the initiation of viral 
assembly. The N-terminal is exposed at the viral particle surface, and as this region is highly variable, 
may allow for the different methods of vector transmission among Potyvirus species. Furthermore, it 
has been shown that the coat protein can undergo post-translational modifications, among them 
phosphorylation, and it is hypothesised that these changes may regulate the allocation of viral RNA 
for translation, replication or propagation. Moreover, the coat protein has NTPase activity that may 
also regulate viral replication and propagation (Revers and García, 2015).    
1.7 CBSV AND UCBSV HAM1H 
 1.7.1 BACKGROUND 
The HAM1h protein found in the CBSV and UCBSV genomes, situated between the viral replicase (NIb) 
protein and coat protein (CP) in the C-proximal part of the polyprotein, is unique to the Ipomovirus 
genus. EuRV is the only other virus to contain such a protein and it also infects plants in the 
Euphorbiaceae family. Together, CBSV, UCBSV and EuRV, represent a small proportion of viruses that 
are able to infect Euphorbiacea plants, suggesting that the HAM1 homologues are a euphorbia host 
adaptation (Monger et al., 2010; Tomlinson et al., 2017). Sequence identity between the CBSD-causing 
viruses and EuRV (34% amino acid identity) is lower than when compared to eukaryotic HAM1 
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homologues (Monger et al., 2010; Winter et al., 2010; Tomlinson et al., 2017). One suggestion is that 
the integration of the HAM1 homologue from a eukaryotic host into these viruses occurred as two 
separate events. It is possible, however, that the uptake of the HAM1 homologue was an ancient event 
that occurred in a common ancestor and that EuRV and the CBSVs evolved separately. Similarly, as 
CBSV and UCBSV show relatively high levels of divergence, especially in the P1 and HAM1h regions 
where they share 59% and 47% amino acid identities respectively, the same two scenarios can be 
suggested for the evolution of the two CBSD viruses (Monger et al., 2010; Winter et al., 2010; 
Tomlinson et al., 2017). Like the CBSV and UCBSV HAM1h proteins, the function of the EuRV HAM1h 
is unknown (Knierim et al., 2016; Tomlinson et al., 2017).  
As the two viruses causing CBSD are only found in Africa, it is assumed that they evolved within East 
Africa in an unidentified species and subsequently jumped from the native host into cassava. 
Furthermore, as two species of CBSD-causing viruses exist, it may suggest that two jumps occurred 
independently, or they may represent the evolution of CBSV in cassava (Monger et al., 2010; 
Tomlinson et al., 2017). CBSV has been detected in the wild perennial species M. glaziovii and it has 
been shown that CMD was transferred from M. glaziovii to cassava through transmission by the 
whitefly vector, and the same could have occurred with CBSVs (Mbanzibwa et al., 2011b; Ogwok et 
al., 2014). It is thought there are other CBSD hosts that could serve as sources of viral inoculum that 
could then go on to adapt to infect cassava again (Monger et al., 2010; Tomlinson et al., 2017).  
Sequence analysis has shown that the HAM1h proteins in the CBSV and UCBSV genomes are 
homologous to the Maf/HAM1 superfamily of NTPases found in organisms from bacteria, frogs, fish 
and humans, sharing some 33 highly conserved amino acid residues, and thus has given the viral 
proteins their name (Mbanzibwa et al., 2009a; 2009b; 2011a). The HAM1h proteins in CBSV and UCBSV 
are thought to have come from cellular origin through the uptake of cellular RNAs from host plants 
into the viral genome – a function that was fundamental in the evolution of viruses in the 
Closteroviridae family – and provides evidence that viruses of the Potyviridae family are capable of 
cellular RNA recombination in their genomes (Mbanzibwa et al., 2011a). Although the CBSV and 
UCBSV species are the only two Ipomovirus species to have this protein, the Ham1h is the most diverse 
region between the two species, sharing approximately only 47% and 51.1% sequence identity, 
depending on the isolates (Winter et al., 2010; Mbanzibwa et al., 2011a). Diversity of this region is 
30% higher than the coat protein sequences which is the second-most diverse region between the 
two viral species (Mbanzibwa et al., 2011a), with around 80% sequence identity between CBSV and 
UCBSV (Winter et al., 2010).  
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Adaptive evolution between CBSV and UCBSV has been proposed through positive selection on the 
UCBSV HAM1h protein sequences and thus may be the reason why CBSD has been able to spread to 
new areas and may continue to do so over the coming years (Mbanzibwa et al., 2011a). Variation in 
the nucleotide sequences between isolates of CBSV show 79.3-95.5% identity and 86.3-99.3% identity 
between UCBSV isolates, though there has been no evidence of recombination between CBSV and 
UCBSV isolates despite the identification of putative homologous recombination sites (Mbanzibwa et 
al., 2011a; Ndunguru et al., 2015; Tomlinson et al., 2017) 
The function of the CBSV and UCBSV HAM1h proteins are yet to be established, but they are thought 
to play a similar role to the NTPases found in prokaryotes and eukaryotes and prevent viral RNA 
mutation during replication. Evidence of purifying selection on the HAM1h sequences found in both 
CBSV and UCBSV indicate a desired retention of this protein, suggesting that the protein does play a 
key role in the viral infection. Based on the evidence that CBSV is the more virulent of the two viruses 
causing CBSD, work carried out in this project was directed towards studying the CBSV HAM1h.  
 1.7.2 PREVIOUS STUDIES ON THE FUNCTION OF HAM1 PROTEINS 
The model organisms S. cerevisiae and E. coli have provided opportunities for the study of not only 
their own HAM1 and HAM1 homologue RdgB, respectively, but how their functions may elucidate the 
mechanisms behind a number of other HAM1 homologues from a variety of organisms, most notably 
humans. The yeast HAM1 and its homologues belong to the inosine triphosphate pyrophosphatases 
(ITPases), a superfamily of highly conserved nucleoside triphosphate pyrophosphatases (NTPases) 
(Galperin et al., 2006). ITPases have been shown to act upon non-canonical nucleotides in nucleotide 
precursor pools that have built up as a result of oxidative stress and prevent their incorporation into 
replicating nucleic acids, helping to reduce the rate of mutagenesis and ensure high-fidelity genomic 
replication (Savchenko et al., 2007; Stepchenkova et al., 2009b). The importance of these proteins is 
shown through their highly conserved functionality from bacteria to eukaryotes (Stepchenkova et al., 
2009b).  
Studies on the viral HAM1h homologue in S. cerevisiae, HAM1, have shown that the yeast HAM1 gene 
does encode a nucleoside triphosphate pyrophosphatase and thus, hydrolyses non-canonical 
nucleotides. It was previously thought that the yeast HAM1 only hydrolyses non-canonical purine 
nucleotides, yet Carlsson et al. (2013) showed that the HAM1 specificity is broader than first thought, 
providing resistance to pyrimidine analogues as well. Further testing of the E. coli HAM1 homologue, 
RdgB, revealed that the highly conserved Serine-Histidine-Arginine (SHR) motif found in all HAM1 
homologues, is located within the cleft of the protein and suggests that this motif may be forming part 
of the active site of all ITPases (Savchenko et al., 2007).  
24 
 
Such studies have drastically increased the knowledge of how the HAM1 and its homologues function 
in model organisms through the use of plate assays. Most assays conducted have involved the use of 
both wild type and HAM1h mutant forms of the model organisms to observe the effect of the applied 
mutagens on their respective phenotypes. The purine base analogue 6-N-hydroxylaminopurine (HAP) 
has often been used in the past as it is a potent mutagen for both prokaryotic and eukaryotic 
organisms (Carlsson et al., 2018). Studies with S. cerevisiae in particular, showed that omission of the 
HAM1 gene conferred hypersensitivity to HAP, but that the HAM1 function can be restored through 
overexpression of the yeast HAM1 (Noskov et al., 1996; Kozmin et al., 1998).  
As the CBSV HAM1h shows homology with these ITPases, it has been hypothesised that the viral 
protein also targets these non-canonical nucleotides. With the cassava hosts also expressing its own 
HAM1, it is thought that perhaps the viral HAM1h specifically targets RNA non-canonical nucleotides 
to prevent viral RNA mutagenesis, though no research into the interactions of the host and viral 
HAM1h proteins has been conducted (Monger et al., 2010; Mbanzibwa et al., 2011a). For CBSV, the 
HAM1h may be playing a vital role as the virus titre is highest in the mature cassava leaves and where 
the oxidative stress induced as a response to infection causes the early senescence of these leaves 
(Mbanzibwa et al., 2009b; Ogwok et al., 2014). The high level of oxidative stress within these cells 
causes damage to the nucleotides and generates high levels of non-canonical bases in the precursor 
pools. The CBSV HAM1h, therefore, may act upon the RNA non-canonical nucleotide bases to prevent 
their incorporation into the replicating viral RNA.  
1.8 RESISTANCE TO CBSD 
With sub-Saharan Africa experiencing some of the fastest population growths in the world, feeding 
this ever-increasing population has become an urgent issue (Legg et al., 2011). CBSD is currently 
managed through the propagation of disease-free stem cuttings and through the spread of CBSV-
tolerant varieties, yet no robust source of resistance has been established (Blagbrough et al., 2010; 
Yadav et al., 2011). The lack of highly resistant CBSD cassava cultivars means that the risk of further 
CBSD spread remains high. Despite the generation and distribution of tolerant CBSD cultivars which 
display foliar symptoms but lack or exhibit mild root necrosis, they still remain susceptible to CBSD 
(Hillocks and Jennings, 2003; Tomlinson et al., 2017). Furthermore, the selection and breeding of 
resistant cassava varieties has proven a time-consuming and difficult process through the challenges 
encountered in resistant traits being introgressed into the farmer- and consumer-favoured germplasm 
(Jennings, 2003; Yadav et al., 2011). The deployment of a clean seed system is therefore imperative 
to prevent the spread of CBSD, but no such clean cassava seed systems exist in most East African 
countries (Tomlinson et al., 2017).  
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Post-transcriptional gene silencing (PTGS) using small interfering (si)RNAs is a promising biotechnology 
tool for the control of CBSD. It uses the plant’s innate defence mechanism to bring about resistance 
to the selected viruses. In transgenic plants, this PTGS is induced through the action of RNA 
interference (RNAi) which triggers sequence-specific RNA degradation with the use of an artificial 
double-stranded (ds)RNA intermediate. This dsRNA intermediate, known as a hairpin, is homologous 
to a selected viral sequence and can be easily created through the fusion of the respective sequence 
in the sense and antisense orientations in one transcript (Vanderschuren et al., 2007; Yadav et al., 
2011; Tatinemi et al., 2012). The hairpin is then cleaved by Dicer proteins and processed into 21-25 
nucleotide siRNAs by the RNA-induced silencing complex (RISC). These siRNA molecules bind to the 
Argonaute (AGO) protein complex to direct the degradation of RNA molecules with sequences 
homologous to the siRNAs, thus conferring plant resistance to the virus (Yadav et al., 2011; Tatinemi 
et al., 2012; Kuria et al., 2017). This RNAi mechanism has already been applied and generated 
resistance to Cucumber mosaic virus, Zucchini yellow mosaic virus, Watermelon mosaic virus 2, Potato 
leaf roll virus, Potato virus Y and Potato virus X, Papaya ring spot virus, as well as Plum pox virus (Yadav 
et al., 2011).  
Viral CP sequences are often used to induce plant resistance to the virus because of its highly 
conserved nature and the multiple roles it plays in the viral life cycle (Monger et al., 2001a; 
Vanderschuren et al., 2007; Yadav et al., 2011). Furthermore, it has been shown that the 3’ end of the 
CP region is highly conserved amongst CBSV isolates (Monger et al. 2001b). The use of this RNAi-
mediated resistance was initially demonstrated in Nicotiana benthamiana, a systemic host for CBSV 
infection, where one third of transgenic plants containing siRNAs against full length regions of CP 
sequences showed resistance to diverse isolates of CBSV and UCBSV (Patil et al., 2011). RNAi-mediated 
resistance has since been used in successfully generating transgenic cassava expressing siRNAs against 
the UCBSV CP sequence, which showed 100% resistance to UCBSV in replicated graft inoculation 
experiments (Yadav et al., 2011). Subsequently, The Virus Resistant Cassava for Africa (VIRCA) was 
established in 2012 to deliver cassava cultivars with enhanced CBSD resistance to farmers in East Africa 
through the use of RNAi mechanisms (Taylor et al., 2012; Wagaba et al., 2017).  
Furthermore, Wagaba et al. (2017) demonstrated field level RNAi-mediated resistance to CBSD 
through expressing coat protein sequences from CBSV and UCBSV in the transgenic cassava cultivar 
TME 204. Not only did the transgenic cassava remain asymptomatic for CBSD, but the results 
demonstrated that this RNAi-mediated resistance could work across all agro-ecological locations 
where cassava is grown, and across the vegetative cropping cycle. This therefore provides a promising 
source for the development of further resistance to both CBSV and UCBSV.  
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Another aspect that could be used to limit CBSD infection within the cassava host is through the 
deposition of callose at the plasmodesmata, with susceptible cassava varieties showing reduced 
accumulation. Increased deposition of callose at the plasmodesmata was enough to restrict viral 
intercellular movement, though it is dependent on the cassava cultivar and viral isolate (Anjanappa et 
al., 2017). Furthermore, the development of full-length infectious clones of CBSV and UCBSV, which is 
ongoing, will enable the site-directed mutagenesis of key viral gene sequences and will aid in the 
elucidation of the protein functions. Ultimately, use of these clones will then be used to identify 
targets for the restriction of viral infection (Tomlinson et al., 2017).  
1.9 AIMS OF THE RESEARCH 
Previous work had demonstrated the ability of using model organisms to test the expression of ITPases 
on different strain phenotypes to determine the protein function. The use of spot assays had enabled 
mutations in specific genes to be identified that made the organism susceptible to the mutagenic 
effects of the accumulation of non-canonical nucleotides. Results of these assays can then, therefore, 
also provide a genetic source of resistance to the selected factors. In terms of disease management, 
knowledge of a viral protein function can be used to induce resistance in the host to combat infection. 
Further studies to elucidate the function of the CBSV HAM1h are therefore warranted as the spread 
of CBSD increases.  
In order to determine the function of the CBSV HAM1h, one method was to test how its functionality 
compared to known HAM1 homologues using previously described spot assays. Firstly, the CBSV 
HAM1h will be overexpressed in wild type S. cerevisiae to test its effect on conferring increased 
resistance to a range of mutagens, and secondly, the effect of its expression in ham1 mutant S. 
cerevisiae will be used to test if the HAM1 function of yeast can be complemented by the viral HAM1h, 
again when exposed to mutagens.  
Given that the host plant of CBSV infection also contains a HAM1 protein, the reasoning behind the 
uptake and retention of the viral HAM1h remains to be fully understood. To date, no studies looking 
at the interaction of the host and viral HAM1 expression levels have been conducted. This project thus 
presents a novel investigation into the effects of the transcript levels of the host HAM1 upon infection 
with CBSV in the model host plant, Nicotiana benthamiana.  
Determination of the role the CBSV HAM1h performs will allow for better understanding of where the 
viral HAM1h originated and why it has been retained. More importantly, such discoveries could 




CHAPTER 2 – MATERIALS AND METHODS 
 
All plastic, glassware and media were autoclaved at 121oC for fifteen minutes before use. Sterile 
deionised water (SDW) was used to prepare all solutions unless otherwise stated. Chemicals and 
media used in this study were purchased from Melford, Sigma-Aldrich or Thermo Fisher Scientific 
unless otherwise stated. Primers were purchased from Integrated DNA Technologies. Commercial 
kits were purchased from Thermo Fisher Scientific or Zymo Research. All microbial culturing was 
performed in a class II biosafety cabinet using a Bunsen burner and sterilised material.  
2.1 STRAINS 
 2.1.1 FUNGAL STRAINS 
  2.1.1.1 SACCHAROMYCES CEREVISIAE  
Saccharomyces cerevisiae strain BY4742 (MATalpha his3Δ leu2Δ lys2Δ ura3Δ) was used as the wild 
type strain in all experiments and for use in yeast recombination experiments.  
S. cerevisiae ham1 knockout deletion strain YJR069C MATalpha, in the background of BY4742 (ham1), 
was obtained from the Yeast Knockout Collective (YKO) from GE healthcare. The strain was used as 
the ham1 mutant strain in all experiments and used for yeast recombination experiments.  
 2.1.2 BACTERIAL STRAINS 
  2.1.2.1 ESCHERICHIA COLI  
Escherichia coli strain DH5α was used for the propagation of plasmids.  
  2.1.2.2 AGROBACTERIUM TUMEFACIENS 
Agrobacterium tumefaciens strain LBA1126 was used for the propagation of the CBSV infectious clone 
and subsequent infection of Nicotiana benthamiana via agroinfiltration.  
2.2 PLASMIDS  
2.2.1 PYES2 VECTOR PLASMIDS 
The plasmid pYES2 was used for its ability to express inserted genes in yeast, and for the presence of 
the URA3 gene to restore the URA function in ura3 deletion strains. Plasmids containing the HAM1 
genes from CBSV (Nampula strain) and S. cerevisiae were generated by digestion of pYES2 and 
pJET_HAM1_Sc or pJET_HAM1_CBSV plasmids with HindIII and SphI restriction enzymes, then 
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subsequent ligation of the HAM1 gene regions with ligated pYES2 using T4 DNA ligase, produced the 
plasmids pYES2_HAM1_Sc and pYES2_HAM1_CBSV. Plasmids were then transformed into 
electrocompetent E. coli DH5α cells. Recovery of the plasmids from the E. coli cells and subsequent 
digestion analysis, confirmed the correct plasmid construction.   
 2.2.2 C6 CASSAVA BROWN STREAK VIRUS INFECTIOUS CLONE 
CBSV infected cassava material from Mikocheni Rd, Tanzania was amplified to produce six overlapping 
RT-PCR fragments covering the full CBSV Tanza genome. Instability of this clone when attempting to 
transform E. coli, meant that three plant introns were inserted into the P3, CI and NIb regions to 
provide sufficient sequence stability for it to be cloned successfully in yeast before propagation into 
the E. coli strain OverExpress C43. The full-length infectious clone was then cloned into a yeast 
adapted pCAMBIA0380 vector, which included the CaMV 35S promoter and the tNOS terminator to 
enable in vivo transcription (made by C. Duff-Farrier, PhD student). This infectious CBSV clone was 
used to transform the A. tumefaciens LBA1126 strain before use in agroinfiltration to inoculate N. 
benthamiana plants.  
2.3 MEDIA 
 2.3.1 SACCHAROMYCES CEREVISIAE MEDIA 
Yeast Peptone Dextrose (YPD) Broth (10g/L yeast extract, 20g/L Bacto-peptone, 20g/L D-glucose, 
0.04g/L adenine sulphate) was used for the cultivation and maintenance of S. cerevisiae. YPD Agar 
(YPDA) was prepared with YPD and the addition of 20g/L agar, and used for the cultivation and 
maintenance of S. cerevisiae.  
Yeast Synthetic Dropout Media (YSDM) Broth (1.7g/L yeast nitrogen base, 5g/L ammonium sulphate, 
20g/L D-glucose, 0.77g/L yeast drop-out mix: -URA, pH 6.8) was used for the selection, cultivation and 
maintenance of the transformed S. cerevisiae. YSDM Agar was prepared with YSDM and the addition 
of 20g/L agar, and was used as a selection medium for the transformed S. cerevisiae and in the yeast 
plate-based assays. Transformation of the ura3 deficient BY4742 and ham1 knockout strains with the 
pYES2.1 plasmid that contains the orotidine 5-phosphate decarboxylase (URA3 gene), enabled their 
selection on media lacking uracil.  
2.3.2 ESCHERICHIA COLI AND AGROBACTERIUM TUMEFACIENS MEDIA 
Luria-Bertani (LB) Broth (25g/L Luria-Bertani) was used for the cultivation and maintenance of E. coli 
and A. tumefaciens.  
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Luria-Bertani (LB) Agar (25g/L Luria-Bertani, 15g/L agar) was used for the cultivation and maintenance 
of E. coli and A. tumefaciens.  
2.3.3 ANTIBIOTIC SELECTION 
Antibiotics were added to supplement the media to allow for the selection of transformants. The 
antibiotics selected depended on the plasmids used for transformation and the resistance genes they 
contained. Table 2.1 shows the antibiotics used, where they were purchased and how they were 
prepared.  
Table 2.1. Details on the antibiotics used in this study.  
Antibiotic Supplier Dissolved in Stock (mg/ml) Working (μg/ml) 
Ampicillin Sigma Aldrich SDW 10 100 
Kanamycin Sigma Aldrich SDW 5 50 
Rifampicin Melford Methanol 20 20 
 
Ampicillin was added to LB media to provide selection for transformed E. coli DH5α cells (LB Amp+), 
while Rifampicin and Kanamycin were added to LB media to provide selection for transformed A. 
tumefaciens LBA1126 cells (LB Rif+ Kan+).  
2.4 CULTURE MAINTENANCE AND STORAGE 
 2.4.1 SACCHAROMYCES CEREVISIAE MAINTENANCE  
S. cerevisiae were grown on YPDA, inverted and incubated at 28oC for two to three days. Liquid 
cultures were established in YPD by inoculating with a single colony taken from an agar plate using a 
flame-sterilised inoculating loop and incubated at 28oC overnight with 200rpm shaking. Transformed 
wild type and ham1 knockout cultures were established and maintained in the same way, instead 
using YSDM.  
 2.4.2 ESCHERICHIA COLI MAINTENANCE  
E. coli DH5α cultures were grown on LB plates with the appropriate antibiotic selection, inverted and 
incubated overnight at 37oC. Liquid cultures were grown by inoculating LB with the appropriate 
antibiotic selection, with a single colony taken from an agar plate using a flame-sterilised inoculating 
loop, and incubated at 37oC overnight with 250rpm shaking.  
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 2.4.3 AGROBACTERIUM TUMEFACIENS MAINTENANCE  
Agrobacterium tumefaciens cultures were grown on LB plates with the appropriate antibiotic 
selection, inverted and incubated overnight at 28oC. Liquid cultures were grown by inoculating LB with 
the appropriate antibiotic selection, with a single colony taken from an agar plate using a flame-
sterilised inoculating loop, and incubated at 28oC overnight with 200rpm shaking.  
 2.4.4 S. CEREVISIAE, E. COLI AND A. TUMEFACIENS STORAGE  
Cultures on agar plates or in liquid media were stored at 4oC for up to four weeks. Glycerol stocks 
(20%) were prepared for long-term storage through the addition of 500μl of 40% glycerol to 500μl of 
fresh microbial liquid culture, before rapidly frozen in liquid nitrogen and stored at -80oC.  
 2.4.5 VIRAL STORAGE 
Infected N. benthamiana tissue samples were rapidly frozen in liquid nitrogen and stored at -80oC.  
2.5 BUFFERS 
 2.5.1 AGROINFILTRATION MES BUFFER 
A solution of 10mM morpholino ethane sulfonic acid (MES) buffer, with the pH adjusted to 5.7 with 
the addition of NaOH, was filter sterilised.  
2.6 MOLECULAR METHODS 
 2.6.1 AGAROSE GEL ELECTROPHORESIS  
  2.6.1.1 AGAROSE GEL PREPARATION 
A 1% (w/v) agarose solution was prepared in TAE buffer (40mM Tris acetate, 1mM EDTA, pH 8.0) for 
the visualisation of DNA fragment bands, and a 2% (w/v) agarose solution was prepared in TAE buffer 
for the visualisation of RNA fragment bands. Both solutions were heated until fully dissolved then 
cooled to between 50 and 60oC before the addition of Midori Green Nucleic Acid Staining Solution 
(Bulldog Bio). The solutions were poured into a UV-transparent gel tray (Bio-Rad), enclosed in a gel 
cast (Bio-Rad) and wells were formed using a gel comb. The gel combs were removed once the gels 
had set, the gels were placed in the electrophoresis tanks (Bio-Rad) and covered with TAE buffer.  
  2.6.1.2 LOADING AND RUNNING GELS 
With the exception of PCR products generated using DreamTaq® DNA Polymerase (Thermo Fisher 
Scientific), a 5x loading dye (Bioline) was used for all nucleic acid samples. Hyperladder 1 (Bioline) (Fig. 
2.1) was used as a molecular weight marker to deduce the size of the nucleic acid fragments and 
concentration, with 5μl loaded onto the gel alongside the samples. 5-10μl of each nucleic acid sample 
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was then loaded onto the gel and gels were typically run at 120V for thirty minutes on 1% agarose 
gels, or 80V for forty minutes on 2% agarose gels.  
Figure 2.1. Hyperladder 1 (Bioline) is used as a molecular weight marker in gel electrophoresis (reproduced from 
https://www.bioline.com/uk/hyperladder-1kb.html). 
  2.6.1.3 VISUALISATION OF NUCLEIC ACIDS 
Midori Green intercalates with the nucleic acids and fluoresces green under UV light, allowing for their 
visualisation. Visualisation was achieved using the Bio-Rad Gel Doc 2000 Imaging System.  
 2.6.2 PLASMID EXTRACTION 
  2.6.2.1 ESCHERICHIA COLI  
A single colony of transformed E. coli was inoculated into 5ml LB with the appropriate antibiotic 
selection and grown at 37oC overnight with 250rpm shaking. The plasmid extraction was carried out 
in accordance with the Thermo Fisher Scientific GeneJET Plasmid Miniprep Kit, where the cultures 
were lysed, centrifuged, and the plasmid DNA, contained in the lysate, was bound to silica membranes 
under high salt conditions. The plasmid DNA was then purified through a series of washing steps 
before elution from the column.   
  2.6.2.2 SACCHAROMYCES CEREVISIAE 
A single colony of transformed S. cerevisiae was inoculated into 5ml YSDM and grown at 28oC 
overnight with 200rpm shaking. The plasmid extraction was carried out in accordance with the 
Zymoprep™ Yeast Plasmid Miniprep I Kit with some minor adjustments: 3ml of the overnight culture 
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was used in the process instead of the stated 0.5-1.0ml; and following the addition of Zymolase, the 
mixtures were incubated for two hours instead of the stated 15-60 minutes.  
2.6.3 RESTRICTION ENZYME DIGESTION 
Restriction enzyme digestion was carried out on the purified plasmids to verify the plasmids obtained, 
to check no transposons had been inserted and for use in yeast homologous recombination. 
Restriction enzymes were purchased from Thermo Fisher Scientific. 1μl of the chosen restriction 
enzyme was added to 4μl of the extracted plasmid. 2μl of the corresponding buffer solution was added 
and then 13μl of sterilised water. The solution was incubated at 37oC for thirty minutes, before being 
electrophorised on a gel at 100V for forty minutes to visualise the plasmid fragments.  
2.6.4 LOW FIDELITY POLYMERASE CHAIN REACTION (PCR)  
Plasmids were used in PCR to check the plasmid had been taken up correctly in transformants and to 
amplify any genes of interest. Green DreamTaq DNA polymerase (Thermo Fisher Scientific) was used 
in analytical PCR. A 2X DreamTaq master mix was prepared containing 2ml of 10X buffer, 400μl dNTPs 
(40μl of each 10mM dNTP mixed thoroughly with 240μl SDW), 400μl DreamTaq DNA polymerase 
(5U/μl), made up to 10ml with SDW. All designed primers were ordered from Integrated DNA 
Technologies at stock concentrations of 100μM. Primers were diluted to 10μM with SDW prior to use 
in PCR.  
DreamTaq PCR reaction volumes per sample were set up as follows: 
▪ 10μl 2X DreamTaq  
▪ 6μl SDW 
▪ 1μl Forward 10μM Primer 
▪ 1μl Reverse 10μM Primer 
With the addition of 2μl of purified plasmid diluted 1:10 with SDW per sample.  
DreamTaq PCR cycle: 
▪ Initial denaturation – 2 minutes at 95oC 
▪ Denaturation – 30 seconds at 94oC  
▪ Annealing – 30 seconds at 55oC  
▪ Extension – 1kb/min at 72oC   
▪ Final extension – 10 minutes at 72oC 




To screen A. tumefaciens cultures for the presence of transformant plasmids, the initial denaturation 
time at 95oC was increased from two minutes to ten minutes.  
 2.6.5 TRANSFORMATION OF ELECTROCOMPETENT AGROBACTERIUM TUMEFACIENS LBA1126 
An aliquot of electrocompetent A. tumefaciens LBA1126 cells was removed from the -80oC stores and 
thawed on ice. Up to 2μl of low-salt DNA sample was added. The A. tumefaciens-DNA mix was 
transferred to an ice-cold sterile 0.2cm Bio-Rad electroporation cuvette. Cells were then 
electroporated using 400 Ohms, 2.5V in the Bio-Rad GenePulser. 900μl LB was then added to the 
cuvette and the mixture transferred to a 1.5ml Eppendorf tube. The solution was incubated for three 
hours in an orbital shaker at 28oC. An appropriate volume was then spread onto LB agar plates 
containing the appropriate antibiotic selection, inverted and incubated at 28oC for 48 hours.  
 2.6.6 AGROINFILTRATION  
Three liquid cultures of the transformed A. tumefaciens LBA1126 were grown overnight. PCR was then 
carried out on these solutions to determine how many had successfully taken up the plasmid, with 
PCR carried out as described above. Once it had been established which of the three overnight cultures 
would be best for use in agroinfiltration, a 50μl aliquot of the culture was added to a fresh universal 
containing 10ml LB with 200μl 10mM MES buffer, 10μl Kanamycin, 10μl Rifampicin and 15μl 
acetosyringone. The solution was then incubated at 28oC with 200rpm shaking for 12-20 hours. 10ml 
of the culture solution was placed into a 50ml Falcon tube then centrifuged at 4oC at 6,000rpm for ten 
minutes. The supernatant was decanted, and the pellet washed with a mixture of 10ml SDW and 200μl 
MES buffer. The solution was centrifuged again at 4oC at 6,000rpm for ten minutes. The supernatant 
was decanted, and the pellet resuspended in a solution of 50ml SDW, 200μl MES buffer, 50μl MgCl2 
and 15μl acetosyringone. This solution was added a few millilitres at a time until the solution became 
less cloudy and about to clear. The culture was then incubated at room temperature for two to five 
hours. After incubation, the solution was then infiltrated onto the underside of Nicotiana 
benthamiana leaves using a 1 or 3ml syringe.  
 2.6.7 SACCHAROMYCES CEREVISIAE TRANSFORMATION 
The LiAc/SS carrier DNA/PEG method, as described by Gietz and Schiestl (2007), for yeast homologous 
recombination was used to transform the S. cerevisiae cells. 
Once the plasmid was extracted from E. coli and confirmed as correct through a plasmid restriction 
enzyme digestion, it was then used to transform S. cerevisiae BY4742 and ham1 knockout cells. 
BY4742 and ham1 knockout yeast liquid cultures were grown overnight at 28oC. The yeast starter 
cultures were poured into 40ml YPD and incubated for four and a half hours at 28oC with 200rpm 
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shaking. The cultures were then transferred to a 50ml Falcon tube and centrifuged for five minutes at 
3,000 x g. The supernatant was discarded, and the cells resuspended in 25ml SDW and centrifuged 
again at 3,000 x g for five minutes. The supernatant was discarded, and the cells resuspended in 1ml 
0.1M LiOAc and transferred to a 1.5ml Eppendorf tube. The cells were pelleted at 13,000rpm for 
fifteen seconds, and the supernatant removed. The cells were resuspended in 400μl of 0.1M LiOAc, 
vortexed and 50μl aliquots were transferred to new tubes, one per transformation. Cells were pelleted 
for a further fifteen seconds and the supernatant removed. Components were added to each 
transformation tube in the following order: 240μl 50% polyethylene glycol 3350 (PEG), 36μl 1M LiOAc, 
50μl salmon-sperm DNA (boiled at 95oC for five minutes and then chilled on ice) and 34μl DNA 
fragments (10μl DNA:24μl SDW). The cells were mixed in this solution by pipetting for one minute. 
The cells were then incubated at 30oC for thirty minutes, followed by incubation at 42oC for a further 
thirty minutes. The cells were then pelleted at 6,000rpm for fifteen seconds and the supernatant 
removed. Cells were resuspended in 500μl sterile water by pipetting, and 100μl of the mixtures were 
spread onto YSDM plates before being inverted and incubated at 28oC for two to three days. 
Confirmation of transformation was established through growth of transformed cells on the YSDM 
agar plates.  
 2.6.8 RNA EXTRACTION USING TRIZOL 
The TRIzol protocol was established by Chomczynski and Sacchi in 1987 and is now a common method 
of extracting total RNA from cells. It takes longer than column-based methods but yields more RNA 
that is generally of a better quality.  
The frozen healthy and infected tissue samples were ground in sterile pestles and mortars with liquid 
nitrogen to a fine powder. The ground samples were vortexed with 0.75ml TRIzol per 0.25ml of sample 
tissue. The homogenised samples were incubated for five minutes at room temperature to enable the 
complete dissociation of the nucleoprotein complex. 0.2ml of chloroform was added per 1ml TRIzol 
added and shaken for fifteen seconds before incubation at room temperature for three minutes. The 
samples were centrifuged at 12,000 x g for fifteen minutes at 4oC. The upper aqueous phase was 
transferred to a new Eppendorf tube with 0.5ml of ice-cold isopropanol, and gently inverted before 
being incubated at room temperature for ten minutes. The addition of chloroform, centrifugation and 
removal of the upper aqueous phase was repeated to maximise the amount of RNA extracted. The 
incubated samples were centrifuged with isopropanol at 12,000 x g for ten minutes at 4oC. The 
isopropanol was removed, and the pellet washed with 1ml of 75% ethanol. The sample was vortexed, 
then centrifuged at 7,500 x g for five minutes at 4oC. The pellets were air dried for ten minutes then 
resuspended in 50μl DEPC treated water.  
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Extracted RNA (5μl) was run with 3μl of loading dye in a gel electrophoresis to check for the presence 
of RNA following the RNA extraction method.  
 2.6.9 FIRST-STRAND CDNA SYNTHESIS 
  2.6.9.1 RNA CONCENTRATION DETERMINATION 
To determine the concentration of extracted RNA in the sample, a nanodrop was used. The nanodrop 
measures the amount of ultraviolet light that passes through the nucleic acid sample, the optical 
density, and thus determines the concentration of nucleic acid in the sample. To obtain the 
concentration of RNA, 1μl of the sample was pipetted onto the nanodrop pedestal and the 
measurement taken. The DEPC water that the RNA pellet was resuspended in, was used as the control 
measurement. The nanodrop also provides measurements of the nucleic acid purity in the sample.  
  2.6.9.2 REMOVAL OF GENOMIC DNA 
In order to progress to the synthesis of first-strand cDNA, the genomic DNA was removed from the 
sample in accordance with the Thermo Fisher Scientific protocol to ensure cDNA was synthesised from 
the RNA extracted from the tissue samples. To remove the genomic DNA, 0.5 μl of DNase and 0.5μl of 
buffer solution was added to 4μl of the extracted RNA samples. This solution was incubated at 37oC 
for one hour. 0.5μl of EDTA was then added to the solution before incubation at 65oC for ten minutes.  
  2.6.9.3 FIRST-STRAND CDNA SYNTHESIS 
The concentration of RNA obtained from the nanodrop measurements was required in this process to 
ascertain how much had to be added in order that a similar concentration of cDNA was produced for 
all the samples. The reaction was conducted in accordance with the Thermo Fisher Scientific protocol: 
▪ 2-5μl RNA (dependent on the sample concentration) 
▪ 1μl oligo(dT) primer 
▪ Nuclease-free water to a volume of 11μl  
The solution was incubated at 65oC for five minutes. The following was then added: 
▪ 4μl reaction buffer  
▪ 1μl RiboLock RNase inhibitor  
▪ 2μl 10mM dNTP mix 
▪ 2μl reverse transcriptase  
The solution was then incubated at 37oC for one hour.  
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  2.6.9.4 CDNA CONCENTRATION DETERMINATION 
The concentration of cDNA synthesised in each sample was measured using the nanodrop. The same 
process was carried out as above with determining the concentration of RNA in the sample, but 
nuclease-free water was used as the control measurement instead of the DEPC water used for RNA 
samples.  
 2.6.10 QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR) 
  2.6.10.1 POLYMERASE CHAIN REACTION 
To further check the cDNA samples synthesised and to check the affinity of the primers for the 
housekeeping gene and gene of interest, PCR with the selected primers was carried out on the cDNA 
samples.  
The DreamTaq polymerase reaction was set up as detailed above with the addition of 2μl cDNA 
sample, and the PCR cycle carried out as follows: 
▪ Initial denaturation – 2 minutes at 95oC 
▪ Denaturation – 30 seconds at 94oC  
▪ Annealing – 30 seconds at 52oC  
▪ Extension – 25 seconds at 72oC  
▪ Final extension – 10 minutes at 72oC 
The PCR products were then visualised following gel electrophoresis on 2% agarose gel to allow for 
better separation of the DNA fragments.  
  2.6.10.2 QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR) 
Quantitative Polymerase Chain Reaction (qPCR) is used to ascertain the relative transcription levels of 
a gene of interest compared to that of a housekeeping gene. qPCR uses fluorescent reporters to 
quantify the generation of DNA in samples, with SYBR Green I dye being the most commonly used. 
The dyes fluoresce when intercalated with double-stranded DNA. The Thermo Fisher Scientific 
Maxima SYBR Green/ROX qPCR Master Mix (2X) was used, and the reaction set up as follows per 
sample with the addition of appropriate control samples: 
▪ 12.5μl Maxima SYBR Green/ROX qPCR Master Mix (2X)  
▪ 0.3μM Forward Primer 
▪ 0.3μM Reverse Primer 
▪ ≤500ng Template DNA 




The PCR tubes were gently mixed, and the thermal cycler programmed as detailed below: 
▪ Initial denaturation – 10 minutes at 95oC 
▪ Denaturation – 30 seconds at 95oC  
▪ Annealing – 1 minute at 52oC  
▪ Extension – 1 minute at 72oC 
▪ 1 minute at 95oC 
▪ 30 seconds at 55oC 
▪ 30 seconds at 95oC 
The samples were placed in the cycler and the programme started. Data is acquired during the 
extension stage and is recorded as the cycle threshold (Ct) values on amplification plots.  
qPCR products were then run on a 2% agarose gel to check the size of the DNA fragments and that 
they were of the expected size given the primers used.    
2.7 PLATE-BASED ASSAYS 
 2.7.1 MUTAGEN STOCK CONCENTRATIONS 
Mutagenic compounds were ordered from Sigma-Aldrich. Stock concentrations were made using 
dimethyl sulfoxide (DMSO) (purchased from Sigma-Aldrich) as the solvent, see Table 2.2. Solutions 
were made in a fume hood as highly toxic chemicals were used.  
Table 2.2. Stock and working concentrations of mutagenic compounds.  
Mutagen Dissolved in Stock (mg/ml) Working (μg/ml) 
Cycloheximide DMSO 0.1 0.045, 0.080, 0.1, 
0.13 
5-fluoruracil  DMSO 10 10, 40, 60, 80 
5-flucytosine DMSO 10 20, 40, 60, 100 
Methotrexate DMSO 10 10, 40, 60, 80 
Bromodeoxyuridine DMSO 10 76, 153, 307, 460 
6-azauracil DMSO 10 500, 1000, 2000, 
4000 
 2.7.2 PRODUCTION OF MEDIA 
YSDM plates were made up, half of which contained 20% galactose which was added following the 
autoclaving of the media. The corresponding volume of stock solution for each mutagen was added 




 2.7.3 YEAST SPOTTING 
Single colonies of the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV transformed wild type and 
ham1 knockout yeast were grown in YSDM overnight at 28oC with 200rpm shaking for 16-18 hours 
until all colonies showed stationary phase growth (OD600 > 1.5). Overnight cultures were diluted in 
fresh media to a final optical density of 0.1 (OD600 = 0.1) in 250ml conical flasks and were incubated 
again for a further 3-5 hours at 28oC with 200rpm shaking until the cultures were grown to mid-log 
phase (OD600 = 0.4-0.6). The cells were harvested by centrifugation for five minutes at 3,000 x g. The 
pellets were resuspended in 25ml SDW and centrifuged again as before. The pellets were then 
resuspended in 1ml SDW and transferred to 1.5ml Eppendorf tubes. The supernatant was discarded 
following centrifugation for fifteen seconds at 13,000rpm and the pellets resuspended in 1ml SDW. 
Four ten-fold serial dilutions were performed, giving the final cell concentrations of 1, 10-1, 10-2, 10-3 
and 10-4. 5μl aliquots of the serial yeast cell dilutions were spotted onto the YSDM plates (Fig. 2.2) 
with the corresponding concentrations of mutagen, and with or without the addition of 20% 
galactose.  
 
Figure 2.2. Diagram of the placement of the transformed yeast spots, from a cell concentration of 1 to a cell concentration 
of 10-4 dilution, on the YSDM plates.  
2.8 PLANT METHODS 
 2.8.1 PLANT MAINTENANCE 
N. benthamiana plants were maintained at 25oC in growth chambers on a 16-hour light/8-hour dark 





10-2 10-3 10-4 
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 2.8.2 PLANT INOCULATION 
  2.8.2.1 INOCULATION OF CASSAVA BROWN STREAK VIRUS 
Inoculation of two-week-old N. benthamiana seedlings with Cassava brown streak virus was carried 
out using the Agroinfiltration method as described above. Detection of viral infection was monitored 
up to two weeks following inoculation by recording symptoms.  
  2.8.2.2 INOCULATION OF TOBACCO MOSAIC VIRUS 
Inoculation of two-week-old N. benthamiana seedlings with Tobacco mosaic virus was carried out via 
sap inoculum. A TMV infected N. benthamiana leaf sample was ground to a fine powder in a pestle 
and mortar using liquid nitrogen. SDW was then added and mixed with the ground sample. 
Carborundum was dusted onto the selected healthy N. benthamiana leaf, and gloved fingers were 
used to gently rub the sap inoculum onto the leaf. The leaf was left to dry for ten minutes before 
excess carborundum was rinsed off using SDW.   
 2.8.3 COLLECTION OF RNA SAMPLES 
Tissues samples were taken from healthy and infected N. benthamiana plants eighteen days post 
inoculation, using sterile gloves, and placed into labelled sterile Eppendorf tubes. The samples were 















CHAPTER 3 – INVESTIGATING THE FUNCTION OF 
THE CBSV HAM1H BY EXPRESSION IN YEAST 
 
3.1 BACKGROUND INFORMATION 
All organisms are subject to the effects of exogenous and endogenous nucleic acid damaging agents, 
which when accumulated, cause replication infidelity and genomic instability. One such causal agent 
of nucleic acid damage, is the accumulation of non-canonical nucleotides in cellular precursor pools 
(Menezes et al., 2012) brought about through the oxidation, deamination and other modifications of 
nucleotides (Kozmin et al., 2000; Galperin et al., 2006; Savchenko et al., 2007). Most often these non-
canonical nucleotides are created naturally in the cell as by-products in the pathways of purine and 
pyrimidine synthesis, or they arise as a result of the cell being under oxidative stress (Simandan et al., 
1998, Kozmin et al., 2000). This intracellular production of non-canonical (deoxy)nucleoside 
triphosphates ((d)NTPs), such as (deoxy)inosine triphosphate ((d)ITP) and (deoxy)xanthosine 
triphosphate ((d)XTP), can be incorporated into DNA and RNA during replication or transcription by 
the DNA and RNA polymerases (Savchenko et al., 2007). This incorporation of such bases is highly 
mutagenic due to the mispairing of nucleotides and can result in cell death as a result of the many 
nicks in the nucleic acid caused by the cell repair mechanisms (Kozmin et al., 2000). Indeed, this base 
mispairing can go unrecognised by the cell repair systems in both E. coli and S. cerevisiae (Kozmin et 
al., 1998). The mutagenic non-canonical nucleotides, therefore, must be removed from the precursor 
pools before their incorporation into synthesising nucleic acids.  
Non-canonical NTPs are removed from the cellular nucleotide precursor pools by ‘house-cleaning’ 
enzymes, nucleoside triphosphate pyrophosphatases (NTPases). One such superfamily of NTPases is 
the highly conserved inosine triphosphate pyrophosphatases (ITPases), which contain the HAM1 
protein and its homologues (Galperin et al., 2006). The importance of the role these proteins play in 
the organisms to ensure high fidelity genome amplification is demonstrated through their highly 
conserved functionality from bacteria and archaea, through to eukaryotes (Stepchenkova et al., 
2009b).  
Previous experiments have demonstrated the functionality of theses ITPases when tested against 
potent mutagens with the deletion or overexpression of the gene of interest using spot assay 
methodologies. In most of these investigations, 6-N-hydroxylaminopurine (HAP), a known mutagen 
for both prokaryotic and eukaryotic organisms, was used (Pavlov et al. 1996). HAP is an adenine base 
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analogue and due to its toxicity to bacteria, yeast and eukaryotic cells, it has been termed a universal 
mutagen (Kozmin et al., 2000). Initial studies carried out in S. cerevisiae showed that a ham1 mutant 
strain was hypersensitive to HAP, though it was shown that the HAM1 function could be restored 
through overexpression of the yeast HAM1, and due to their highly conserved functionality, even as a 
result of the overexpression of HAM1 homologues from E. coli and humans (Noskov et al., 1996; 
Kozmin et al., 1998; Hwang et al., 1999; Stepchenkova et al., 2009b). Furthermore, Kozmin et al. (1998) 
showed that the overexpression of the yeast HAM1 gene functions in E. coli just as it does naturally in 
yeast and that this overproduction of yeast HAM1 brought about a significant reduction in sensitivity 
to HAP. Work by Carlsson et al. (2013; 2018) showed that overexpression of the yeast HAM1 in yeast 
ham1 mutant strains, was able to confer increased resistance to pyrimidine analogues as well as 
purine analogues. Similarly, RdgB, which has been identified as the ITPase homologue in E. coli, does 
not discriminate between deoxyribonucleotides and ribonucleotides, and has demonstrated high 
nucleotide pyrophosphatase activity against three non-canonical NTPs (ITP, dITP and dXTP) while 
maintaining low pyrophosphatase activity against some eight canonical nucleotides (Savchenko et al., 
2007). This discrimination was also found through the action of those ITPases found in archaea and 
eukaryotes, and thus suggests that the functional part of these proteins is highly conserved 
(Savchenko et al., 2007; Carlsson et al., 2013). Most ITPases in the HAM1 family contain a signature 
Serine-Histidine-Arginine (SHR) motif, and Savchenko et al. (2007) have already demonstrated that 
this signature HAM1 motif has been found inside a cleft that they propose forms part of the active site 
of the RdgB protein in E. coli. The CBSV HAM1h has been shown to contain this highly conserved SHR 
motif (Mbanzibwa et al., 2009b) and thus is speculated to function in much the same way as other 
ITPases.  
3.2 AIMS 
The aim of this investigation was to determine if the CBSV HAM1h functions in the same was as other 
ITPases by providing a direct comparative study to other known HAM1 homologues. It was proposed 
to use spot assays, as described previously by Carlsson et al. (2013), to provide a suitable 
experimentation technique to observe the effects of the expression and overexpression of the CBSV 
HAM1h on the phenotypes displayed in ham1 mutant and wild type strains of S. cerevisiae 
respectively, when exposed to increasing concentrations of mutagens. Yeast was selected as the host 
model organism despite the fact that E. coli is more sensitive to a greater range of purine and 
pyrimidine analogues than eukaryotic cells (Kozmin et al., 1998), as the correct mutation in E. coli for 
use in this study was not available. In addition, HAP was no longer commercially available due to its 
highly toxic effects and so this mutagen could not be used in the spot assays. Instead, work by Carlsson 
et al. (2013) showed that the yeast HAM1 was able to confer increased resistance to a pyrimidine 
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analogue, 5-fluorouracil. Two other known mutagens that disrupt nucleic acid synthesis and 
replication, cycloheximide and methotrexate, were also used.  
3.3 PLASMID DESIGN AND CONFIRMATION 
HAM1 genes from CBSV and yeast were inserted into the pYES2 plasmid downstream of the inducible 
GAL1 promoter by ligation of sticky ends following digestion with restriction enzymes (supplied by J. 
Miller, PhD student). The correct insertion of the HAM1 genes in the pYES2_HAM1_Sc and the 
pYES2_HAM1_CBSV plasmid constructs were confirmed previously through use of PCR analysis with 
specific primer pairs for the respective genes, and through plasmid digests with selected restriction 
enzymes which have unique sites in the constructs. Stores of the plasmid constructs transformed into 
electrocompetent E. coli DH5α were used to subsequently extract the plasmid constructs using the 
Thermo Scientific GeneJet Plasmid Miniprep Kit according to the manufacturer’s protocol. To further 
confirm the correct construction of the plasmids and to ensure that no contamination had occurred, 
a restriction digest was carried out. The digest uses restriction enzymes to cut the plasmid at specific 
points to generate fragments of certain sizes depending on the plasmid construct. For this, the 
restriction enzyme ScaI was used as it contains three specific sites in the pYES2_HAM1_Sc plasmid 
construct (Fig. 3.1.A), and only two in the pYES2_HAM1_CBSV plasmid construct (Fig. 3.1.B). The 
plasmid digest was also carried out the pYES2 empty vector construct, which will provide a control in 
the yeast spot assays, and like the pYES2_HAM1_CBSV plasmid construct, contains two sites specific 















Figure 3.1. Plasmid maps of the constructs generated from the ligation of pYES2 and the HAM1 genes from either S. 
cerevisiae or CBSV to give A. pYES2_HAM1_Sc and B. pYES2_HAM1_CBSV. Restriction enzymes used for the digestion of the 
plasmid constructs are shown, with ScaI being common to both. 
Following digestion of the plasmid constructs with the restriction enzyme ScaI, the fragments were 
visualised using gel electrophoresis with Midori Green staining. Visualisation of the fragments after 
the subsequent digest of the pYES2_HAM1_Sc plasmid verified that three fragments were produced 
of sizes 3631 base pairs (bps), 1845 bps and 893 bps (Fig. 3.2). Furthermore, visualisation of the 
fragments following the digestion of the pYES2_HAM1_CBSV plasmid verified that two fragments 
were produced of sizes 5566 bps and 893 bps (Fig. 3.2).   
 
Figure 3.2. Gel electrophoresis of the fragments generated from the plasmid digest with the ScaI restriction enzyme of the 
pYES2 empty vector (lane 1), pYES2_HAM1_Sc (lane 2) and pYES2_HAM1_CBSV (lane 3) plasmid constructs recovered from 
transformed E. coli. 
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Following the confirmation that the plasmid constructs are all correct and have not been 
contaminated, the plasmids were transformed into wild type and ham1 mutant S. cerevisiae strains. 
Confirmation of the transformation of the yeast cells was determined by the ability of the 
transformants to grow on synthetic drop-out media (YSDM) which lacks uracil. Only those yeast cells 
that had successfully taken up the plasmid constructs would be able to grow as the pYES2 vector 
contains the URA3 gene. Yeast not expressing a URA3 gene would not be able to grow on the YSDM. 
Successful transformants were then used in the yeast spot assays following four series of ten-fold cell 
dilutions.  
3.4 SCORING OF THE SPOT ASSAYS 
The serial dilutions of the transformed yeast cells were then spotted onto plates of YSDM media 
containing the varying concentrations of the chosen mutagens (GAL-), with half supplemented with 
20% galactose (GAL+). Addition of galactose will induce the expression of the HAM1 genes, if present, 
transformed into the yeast cells, leading to either the overexpression of HAM1 in the wild type yeast 
cells, or expression of a HAM1 gene in the ham1 mutant cells. Results of the yeast spot assays were 
then scored according to the number of colonies present and the intensity of growth. The number of 
cells present were scored from 1-5, with one representing the growth of one colony up to a number 
of five, and five representing the growth of visibly more than thirty colonies. The intensity of growth 
was scored from 1-4, with the differentiation as labelled in Fig. 3.3. The values scored for the growth 
of the transformed yeast strains at each serial dilution with increasing concentrations of the applied 
mutagens, were multiplied together to give one combined value that was more sensitive to the 
phenotypes displayed. This more sensitive method of scoring enabled subtle differences to become 





Figure 3.3. Key showing the scoring system from 1-4 of the growth intensities of the yeast cells, highlighted by the white 







Following on from the scoring of the yeast growth in the plate assays, statistical analyses were carried 
out to confirm if there were any significant differences between the growth of the yeast cells when 
grown in conditions with or without the supplemented galactose. Multiple two-way ANOVA analyses 
were determined to be most appropriate for these results.  
3.5 CYCLOHEXIMIDE RESISTANCE ASSAY 
Cycloheximide (CHX) was first discovered as an anti-fungal compound produced by the gram-positive 
bacterium Streptomyces griseus, but has been later described as a glutarimide antibiotic. It is a cell-
permeable molecule that specifically binds to the 60S ribosomal subunit where it inhibits eukaryotic 
cytosolic translation (Alamgir et al., 2010; Buchanan et al., 2016). As a result, the potent inhibition of 
the ribosome prevents translation elongation causing defects in protein synthesis, and when exposed 
to high levels of CHX, S. cerevisiae has been shown to cease protein synthesis and cell growth 
(Gerlinger et al., 1997; Alamgir et al., 2010; Schneider-Poetsch et al., 2010). At lower concentrations 
of CHX, however, it can be used to test the function of the yeast HAM1 and HAM1 homologues 
(Alamgir et al., 2010).  
3.5.1 OVEREXPRESSION OF HAM1 
At high cell densities, at the 10-2 cell dilution (Fig. 3.4), there was no readily apparent difference in 
growth caused by the overexpression of either the yeast or CBSV HAM1 genes when induced by the 
supplemented galactose. Despite an increase in growth of those wild type cells overexpressing HAM1 
genes from yeast and CBSV under the influence of galactose from CHX concentrations of 80, 100 and 
130ng/ml, cells transformed with the empty pYES2 vector, and thus not overexpressing a HAM1 gene, 
also showed increases in growth. Indeed, at the CHX concentration of 80ng/ml, all the transformed 
cells showed significant differences in cell growth with the added galactose (pYES2, p = 0.0161; 
HAM1_Sc, p = 0.0161; HAM1_CBSV, p = 0.0399). At the CHX concentration of 100ng/ml, however, 
none of the transformed cells showed a significant difference in growth (pYES2, p = 0.374; HAM1_Sc, 
p = 0.116; HAM1_CBSV, p = 0.374). There was, however, one significant result that was not also 
observed in the pYES2 transformed cells. At the CHX concentration of 130ng/ml, a significant 
difference in the cell growth of the pYES2_HAM1_Sc transformed cells was observed with the addition 
of the 20% galactose (p < 0.001). Despite this one significant result, however, there seems to be no 
readily apparent increase in resistance to the toxic effects of CHX from overexpressing the yeast or 




Figure 3.4. Bar chart showing the average growth scores (n=3) at the 10-2 cell dilution of the wild type S. cerevisiae cells 
transformed with the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids with increasing concentration of 
cycloheximide compound, with and without supplemented galactose. 
At lower cell densities, when considering resistance to CHX at the concentration of 45ng/ml, it 
becomes apparent that those yeast cells overexpressing the HAM1 genes from yeast and CBSV show 
increased growth, and therefore increased resistance to the mutagen, compared to those transformed 
with the empty pYES2 vector at the 10-3 and 10-4 cell dilutions (Fig. 3.5), which saw no effect on their 
growth upon the addition of galactose to the media. Indeed, statistical analysis of the results has 
shown that the growth of the pYES2_HAM1_Sc and pYES2_HAM1_CBSV transformed cells was 
significantly different with the addition of galactose at these cell dilutions (HAM1_Sc, p < 0.001; 
HAM1_CBSV, p < 0.001). These results thus show that overexpression of a yeast HAM1 gene does 
confer increased resistance to the toxic effects of CHX and that the CBSV HAM1 shows similar 




































Figure 3.5. Bar chart showing the average growth scores (n=3) of the wild type S. cerevisiae cells transformed with the 
pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-3 and 10-4 cell dilutions at a concentration of 45ng/ml 
cycloheximide, with and without supplemented galactose. 
Focusing on just the 10-3 cell dilution of yeast (Fig. 3.6), the wild type yeast cells overexpressing the 
HAM1 genes from S. cerevisiae and CBSV under the induction of galactose, show an increase in growth 
across all concentrations of CHX, with the differences in growth being significant at the CHX 
concentration of 45ng/ml (HAM1_Sc, p < 0.001; HAM1_CBSV, p < 0.001). At the CHX concentration of 
80ng/ml, however, the marked increase in growth recorded for cells overexpressing the yeast HAM1 
gene is also observed for those cells transformed with the empty pYES2 vector, thus, no apparent 
effect of overexpressing a HAM1 gene can be deduced, with any differences in growth analysed as not 
being significant (pYES2, p = 0.0161; HAM1_Sc, p = 0.0907; HAM1_CBSV, p = 0.238). Similarly, at the 
CHX concentration of 100ng/ml, there is an increase in growth recorded for the cells not 
overexpressing a HAM1 gene with the addition of galactose, as well as an increase in growth of those 
cells expressing the CBSV HAM1 gene, although these differences are not significant (pYES2, p = 0.374; 
HAM1_CBSV, p = 0.374). Yet as this CHX concentration, there is a significant difference in growth 
observed for those cells now overexpressing the yeast HAM1 (HAM1_Sc, p < 0.001). Again, no 
apparent effect of the overexpression of the CBSV HAM1 gene can be deduced for this serial dilution 
at this CHX concentration. At the CHX concentration of 130ng/ml, an effect of the overexpression of 
the yeast and CBSV HAM1 genes can be seen with increases in growth score observed for both these 
transformed cells under the induction of galactose and comparably, there is no increase for the wild 
type cells transformed with the empty pYES2 vector. The increases in growth observed by those cells 
overexpressing the yeast and CBSV HAM1 genes at the CHX concentration of 130ng/ml, are much 
reduced than at the CHX concentration of 45ng/ml and that is most likely due to the various 
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concentrations of CHX may not be enough to afford full protection to the mutagen, hence why the 
increases in growth scores were likely to not be significant (HAM1_Sc, p = 0.116; HAM1_CBSV, p = 
0.374). This effect was also seen at the 10-4 cell dilution across all concentrations of CHX.  
 
Figure 3.6. Bar chart showing the average growth scores (n=3) of the wild type S. cerevisiae cells transformed with the 
pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-3 cell dilution across all concentrations of 
cycloheximide, with and without supplemented galactose. 
3.5.2 COMPLEMENTATION OF ΔHAM1 
Addition of 20% galactose to the ham1 knockout cells had no readily apparent effect at the CHX 
concentration of 45ng/ml with no increases in growth observed as a result of the expression of the 
yeast or CBSV HAM1 genes (Fig. 3.7.A). An increase in growth was seen for the ham1 knockout cells 
transformed with the pYES2 and pYES2_HAM1_CBSV plasmids at the 10-2 and 10-3 cell dilutions at 
80ng/ml CHX concentration (Fig. 3.7.B), yet these results show no apparent effect on resistance to 
CHX when expressing a HAM1 gene (HAM1_CBSV, p = 0.374 and p = 0.116, respectively). Increases in 
growth were also seen for those cells transformed with the pYES2_HAM1_Sc and pYES2_HAM1_CBSV 
plasmids at the 10-3 cell dilution at 100ng/ml CHX concentration, and for the pYES2_HAM1_Sc 
transformed cells at the 10-4 cell dilution also at this CHX concentration (Fig. 3.7.C). A large increase 
was seen in the growth of the pYES2_HAM1_Sc transformed cells at the 10-4 cell dilution at the CHX 
concentration of 130ng/ml with the addition of 20% galactose, with no growth observed for the pYES2 




























Concentration of Cycloheximide (ng/ml)
pYES2 pYES2_HAM1_Sc pYES2_HAM1_CBSV
pYES2 GAL+ pYES2_HAM1_Sc GAL+ pYES2_HAM1_CBSV GAL+
49 
 
Figure 3.7. Bar charts showing the average growth scores (n=3) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids across all serial dilutions at (A) 45ng/ml (B) 80ng/ml (C) 
100ng/ml and (D) 130ng/ml cycloheximide concentration, with and without supplemented galactose. 
At the 10-3 cell dilution at a CHX concentration of 100ng/ml, cells transformed with the 
pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids showed an increase in growth scores on addition 
of 20% galactose to the agar (Fig. 3.8), though these differences were not significant (HAM1_Sc, p = 
0.116; HAM1_CBSV, p = 0.116). Although not significant, these increases in growth scores were not 
seen for those ham1 knockout cells transformed with the empty pYES2 vector, where there was a 
decrease in growth scores with the galactose supplemented agar, and thus shows that the expression 
of a HAM1 gene, whether from yeast or CBSV, does suggest an increased resistance to CHX under this 
condition. Further replicates in this study, however, would need to be conducted to confirm this trend. 
The increase in growth scores for both the pYES2_HAM1_Sc and pYES2_HAM1_CBSV transformed 
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At the 10-4 cell dilution at the CHX concentration of 100ng/ml, the pYES2_HAM1_Sc transformed cells 
showed an increase in growth under the influence of the supplemented galactose (Fig. 3.8). Although 
not significant (HAM1_Sc, p = 0.374), this result again shows that with more replicates, the expression 
of the HAM1 gene does seem to confer an increased resistance to CHX. Cells transformed with the 
empty pYES2 vector showed no reaction to the addition of galactose and growth decreased to an 
average score of 0.3 (pYES2, p = 0.116). Despite a reduction in average growth score also being 
observed for the pYES2_HAM1_CBSV transformed cells with the addition of galactose (HAM1_CBSV, 
p = 0.374), this reduction in growth was not to the same extent as those cells transformed with the 
empty vector, thus showing that the expression of the CBSV HAM1 gene does still afford some 
protection against the cytotoxic effects of CHX.  
 
Figure 3.8. Bar chart showing the average growth scores (n=3) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-3 and 10-4 cell dilutions at 100ng/ml cycloheximide 
concentration, with and without supplemented galactose. 
No growth was recorded for the ham1 knockout cells transformed with the empty pYES2 vector at the 
10-4 cell dilution at the CHX concentration of 130ng/ml in both GAL+ and GAL- conditions, despite 
growth being recorded for both the pYES2_HAM1_Sc and pYES2_HAM1_CBSV transformed cells in the 
GAL- conditions (Fig. 3.9). With the addition of galactose, the pYES2_HAM1_Sc transformed cells 
showed an increase in growth (HAM1_Sc, p = 0.588). Although not a significant difference, most likely 
due to a lack of replicates, this result suggests a trend where the expression of the yeast HAM1 gene 
does confer greater resistance to the toxic effects of CHX. As was seen at the 10-4 cell dilution at 
100ng/ml CHX concentration, the addition of galactose at the 130ng/ml CHX concentration also saw 
a decrease in growth scores for the pYES2_HAM1_CBSV transformed cells, yet this decrease was 
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it is not possible to see if the scores for the cells expressing the CBSV HAM1 gene are still greater than 
those cells not expressing a HAM1 gene.  
 
Figure 3.9. Bar chart showing the average growth scores (n=3) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-4 cell dilution at 130ng/ml cycloheximide 
concentration, with and without supplemented galactose. 
Overall, most of the effects on increased resistance to CHX were observed at the two highest 
concentrations of CHX or at the greatest cell dilutions (10-3 and 10-4) of the lower concentrations of 
CHX, most notably 45ng/ml. This is probably because at the higher concentrations, CHX is now 
exhibiting greater cytotoxic effects and thus the expression or overexpression of the CBSV and yeast 
HAM1 genes becomes more readily apparent. Indeed, at the greater cell dilutions, the effects of those 
cells expressing or overexpressing HAM1 genes also become more readily apparent. Increases in 
growth scores observed for those wild type cells overexpressing the yeast and CBSV HAM1 genes at 
CHX concentrations of 45ng/ml and 130ng/ml, corroborate the suggestion that the CBSV HAM1 shares 
functionality with the yeast HAM1. Furthermore, expression of these HAM1 genes in the ham1 mutant 
yeast strains at 100ng/ml and 130ng/ml CHX concentration, show that the CBSV HAM1 can 
complement the yeast HAM1.  
3.6 METHOTREXATE RESISTANCE ASSAY 
Methotrexate (MTX) is a folate analogue metabolic inhibitor which ceases the production of 
tetrahydrofolate (THF). The lack of THF prevents the formation of the CH2THF complex and 
subsequently inhibits the biosynthesis of thymidine through the inability of dUMP to be broken down 
into dTMP. Furthermore, the lack of THF prevents purine biosynthesis, and thus, MTX has drastic 





































 3.6.1 OVEREXPRESSION OF HAM1 
At the 10-3 cell dilution at an MTX concentration of 10μg/ml, both the pYES2_HAM1_Sc and 
pYES2_HAM1_CBSV transformed wild type yeast cells show greater growth than those transformed 
with the empty vector (Fig. 3.10). The same scores are also observed with the supplementation of the 
agar with galactose across all three transformants and show that there was no effect on MTX 
resistance from the overexpression of the yeast or CBSV HAM1 genes. It is likely that no effect was 
seen upon the addition of galactose as there were sufficient levels of leaky expression in the GAL- 
conditions to support increased resistance with either the expression of the yeast or CBSV HAM1 
genes at MTX concentrations of 10-60μg/ml. This was not observed at a concentration of 80μg/ml, 
however, where the MTX concentration may have been too high to observe such an effect of any 
HAM1 expression.  
 
Figure 3.10. Bar chart showing the average growth scores (n=3) of the wild type S. cerevisiae cells transformed with the 
pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-3 cell dilution across all concentrations of 
methotrexate, with and without supplemented galactose. 
At the MTX concentration of 40μg/ml, again the growth scores of the cells transformed with the empty 
pYES2 vector remain the same when under the influence of galactose, a result that was expected (Fig. 
3.10). As with the MTX concentration of 10μg/ml, no apparent effect of the overexpression of the 
yeast HAM1 was observed. There was, however, an increase in growth observed when the HAM1 gene 
from CBSV was overexpressed (HAM1_CBSV, p = 0.374). Although not a significant difference, the 
result suggests that the action of the CBSV HAM1 is conferring some increased resistance to MTX, but 
more sensitive assays, and indeed replicates, would need to be conducted to confirm such an effect.  
Despite an insignificant reduction in growth scores for those cells overexpressing the yeast HAM1 gene 
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apparent effect of the overexpression of the CBSV HAM1 gene as well, their growth was much greater 
than those wild type cells not overexpressing a HAM1 gene (Fig. 3.10). However, the decreases in 
growth scores for cells overexpressing the yeast or CBSV HAM1 genes means that little can be inferred 
of their effect on resistance to MTX.  
At the MTX concentration of 80μg/ml, there seems to be very little effect on the growth of the wild 
type S. cerevisiae cells through the overexpression of either the yeast or CBSV HAM1 genes (Fig. 3.10). 
This result is most likely due to the inability of the HAM1 protein alone to be able to continue to afford 
protection to the toxic effects of MTX at that high a concentration. 
3.6.2 COMPLEMENTATION OF ΔHAM1 
Addition of galactose to the ham1 knockout yeast cells at the 10-3 cell dilution for all concentrations 
of MTX (Fig. 3.11) seemed to have little effect on the growth scores of any of the transformed cells 
and in most cases, the growth scores declined, with the results being significantly different for those 
pYES2_HAM1_CBSV (p = 0.050) and pYES2_HAM1_Sc (p < 0.001) transformed cells at the 40μg/ml and 
60μg/ml MTX concentrations, respectively. Some improvement in growth was expected to be seen 
with the addition of the galactose, due to the induction of expression of the yeast and CBSV HAM1 
genes, yet none was observed. A possible explanation why no effect was seen could be that the 
concentration of MTX was not great enough at this cell concentration to really exert its cytotoxic 
effects, although an effect was seen in the wild type yeast assay. Why an effect was seen on the growth 
of the wild type yeast at 80μg/ml MTX but not on the growth of the ham1 knockout yeast, cannot be 
explained.  
 
Figure 3.11. Bar chart showing the average growth scores (n=3) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-3 cell dilution across all concentrations of 
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Under the induction of galactose, the expression of the HAM1 genes from yeast and CBSV do seem to 
have an effect at the 10-4 dilution at the MTX concentration of 10μg/ml (Fig. 3.12), where both 
transformants showed increases in growth scores, though neither results are significantly different 
(HAM1_Sc, p = 0.422; HAM1_CBSV, p = 0.643). This result, however, corroborates the suggestion that 
the CBSV HAM1 does complement the yeast HAM1 by providing increased resistance to MTX.  
Increased resistance to the effects of MTX through the expression of the CBSV HAM1 gene was also 
observed at this 10-4 cell dilution across all concentrations of MTX. The effect of the CBSV HAM1 
expression was most notably seen at the MTX concentration of 60μg/ml, where there was a marked 
decrease with the addition of galactose in the growth of cells not expressing any HAM1, those 
transformed with the pYES2 empty vector, compared to those expressing the CBSV HAM1 which saw 
its growth score double (Fig. 3.12). Due to a lack of replicates, however, neither result was significantly 
different compared to their respective growth scores in GAL- conditions (pYES2, p = 0.374; 
HAM1_CBSV, p = 0.519).  
 
Figure 3.12. Bar chart showing the average growth scores (n=3) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids at the 10-4 cell dilution across all concentrations of 
methotrexate, with and without supplemented galactose. 
The effects of the expression of the yeast HAM1 gene cannot be determined at the two greater 
concentrations of MTX as no growth was observed, either in conditions without galactose or with the 
addition of galactose. 
The only effects on increased resistance to MTX have been observed through the expression of the 
CBSV and yeast HAM1 genes at the greatest cell serial dilutions (10-4). At these cell concentrations, 
the assay seems to have become sensitive enough to observe the subtle differences in phenotypes 
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conducted at this cell concentration and perhaps, even lower cell concentrations. Effects of the 
overexpression of the CBSV HAM1, with the only result observed at the 10-3 cell dilution at 40μg/ml 
MTX, was not enough to determine if the CBSV HAM1 shares functionality with the yeast HAM1 and 
so further assays would need to be conducted to achieve conclusive results.  
3.7 5-FLUOROURACIL RESISTANCE ASSAY 
5-fluorouaracil (5-FU) is a pyrimidine analogue that was designed as an antimetabolite drug to target 
tumour cells for a variety of cancers, from colorectal cancers to breast cancer (Carlsson et al., 2013; 
2018), and thus has been extensively studied especially since the development of resistance to this 
nucleotide analogue within human cells (Carlsson et al., 2013). Antimetabolite drugs usually exert 
their effect by inhibiting essential biosynthetic pathways, or through their uptake into DNA or RNA 
and preventing their normal function as a result of increased levels of mutagenesis. 5-FU carries out 
both; with the misincorporation of fluoronucleotides into RNA and DNA, and the inhibition of 
thymidylate synthase (TS), a nucleotide synthetic enzyme.  
5-FU has the same structure as uracil with a fluorine atom in place of a hydrogen atom at the C-5 
position, with the molecule being taken up into the cell in the same way as uracil. Within the cell, 
however, 5-FU is then converted into three active metabolites: fluorodeoxyuridine monophosphate 
(FdUMP), fluorodeoxyuridine triphosphate (FdUTP) and fluorouridine triphosphate (FUTP) – all of 
which disrupt RNA synthesis and inhibit the action of thymidylate synthase (TS) (Fig. 3.13) (Longley et 





Figure 3.13. Action of the three active metabolites of 5-fluorouracil (FdUMP, FdUTP and FUTP) in the cell that causes 
nucleic acid damage and thymidylate synthase (TS) inhibition (reproduced from Longley et al., 2003). 
The action of TS is crucial for DNA replication and repair within a cell. TS acts through the catalysis of 
the reductive methylation of deoxuyridine monophosphate (dUMP) to deoxythymidine 
monophosphate (dTMP) which provides the sole intracellular production of thymidylate. With the 
presence of 5-FU in the cell, however, the 5-FU FdUMP metabolite instead binds to the nucleotide-
binding site of TS and coupled with CH2THF, forms a stable ternary complex which prevents the binding 
of dUMP. This blocking of the binding of dUMP inhibits the synthesis of dTMP which would normally 
go on to form the thymidylate required for DNA replication and repair (Fig. 3.14). Furthermore, a lack 
of dTMP leads to a depletion in deoxythymidine triphosphate (dTTP) levels which subsequently causes 
imbalances in cellular deoxynucleotide levels, further disrupting DNA synthesis and repair (Fig. 3.14) 
(Longley et al., 2003).  
The increased levels of dUMP brought about through the inhibition of TS action leads to increases of 
deoxyuridine triphosphate (dUTP) and together with the 5-FU metabolite FdUTP, can be 
misincorporated into DNA, a process known as thymineless death. Subsequent repair of the 5-FU 
containing DNA through the action of the nucleotide excision repair enzyme, uracil-DNA-glycosylase 
(UDG), only causes further false-nucleotide incorporation. Eventually, the continual cycle of 
misincorporation and excision results in DNA strand breaks and then cell death. One way to bring 
about resistance to 5-FU is through the action of thymidine kinase which salvages thymidylate from 




Figure 3.14. The binding of dUMP to thymidylate synthase leads to the inhibition of thymidylate, which is required for DNA 
replication and repair, and the increase of nucleotide imbalances which go on to cause damage to the nucleic acids 
(reproduced from Longley et al., 2003). 
Effects of 5-FU on RNA processing and function is just as pronounced as its effects on DNA, with 
disruption being brought about through the extensive incorporation into RNA of the 5-FU metabolite 
FUTP. This misincorporation into RNA inhibits the processing of pre-rRNA into mature rRNA, affects 
the formation of snRNA/protein complexes which then inhibits the splicing of pre-mRNA, as well as 
inhibiting polyadenylation of mRNA even at low concentrations. With these disruptions to RNA 
processing, 5-FU causes severe effects to cellular metabolism and viability, and these effects appear 
to contribute significantly to the cytotoxic effects of the compound (Longley et al., 2003; Carlsson et 
al., 2013).  
 3.7.1 OVEREXPRESSION OF HAM1 
At the 5-FU concentration of 10μg/ml and from the 10-1 cell dilution, the addition of galactose 
consistently caused a reduction in the growth scores of all transformants across all subsequent serial 
dilutions. The same effect was seen for the 5-FU concentration of 40μg/ml from the 10-2 cell dilution 
onwards.  
The only increases in growth for the pYES2_HAM1_Sc transformed cells observed upon the addition 
of galactose were seen at the 10-2 yeast cell dilution at a concentration of 60μg/ml 5-FU (Fig. 3.15), 
however, the increase in growth scores of those wild type S. cerevisiae cells transformed with the 
empty pYES2 vector, suggest that there was no effect on resistance to 5-FU from the overexpression 
of the yeast HAM1, nor was there any effect through the overexpression of the CBSV HAM1. Indeed, 
the increase in growth scores observed at this cell dilution were insignificant (pYES2, p = 0.423; 
HAM1_Sc, p = 0.423). Similarly, at the 10-4 cell dilution, the lack of increase in growth scores for the 
pYES2_HAM1_Sc and pYES2_HAM1_CBSV transformed cells in the presence of the supplemented 
galactose, shows that again, the overexpression of the HAM1 genes did not confer increased 
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resistance to 5-FU. It may be, however, that there is simply not enough HAM1 produced by the cells 
to overcome the cytotoxic effects of 5-FU.  
 
Figure 3.15. Bar chart showing the average growth scores (n=2) of the wild type S. cerevisiae cells transformed with the 
pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids across all serial dilutions at the 5-fluorouracil concentration of 
60μg/ml, with and without supplemented galactose. 
Addition of galactose generally caused the transformed wild type yeast cells to show a reduction in 
growth, an effect that was also found by Carlsson et al. (2013), so no effect on the overexpression of 
the yeast or CBSV HAM1 genes on resistance to 5-FU could be deduced.  
3.7.2 COMPLEMENTATION OF ΔHAM1 
At the 10-2 cell dilution at the 5-FU concentration of 10μg/ml, upon addition of galactose, those ham1 
knockout cells transformed with the pYES2 vector and not expressing a HAM1 gene, show a decrease 
in growth (pYES2, p = 0.423) (Fig. 3.16). This is contrary to what was seen for those cells expressing 
the HAM1 gene from S. cerevisiae which showed an increase in growth with the supplemented 
galactose, though this result was not significant due to a lack of replicates (HAM1_Sc, p = 0.423). 
Despite there being no increase in the growth scores for the pYES2_HAM1_CBSV transformed cells, 
the level of growth remained the same and was the greatest compared to the other two 
transformants. This result shows that expression of the HAM1 gene, either from S. cerevisiae or CBSV, 
does provide protection against the pyrimidine analogue and suggests that the CBSV HAM1 can 
complement that of yeast.  
At the 10-3 cell dilution at this same 5-FU concentration, both the pYES2_HAM1_Sc and 
pYES2_HAM1_CBSV transformed cells showed an increase in growth upon addition of galactose, 
whereas the pYES2 transformed cells showed a decrease (Fig. 3.16). None of these results were 


























S. cerevisiae Cell Dilution
pYES2 pYES2_HAM1_Sc pYES2_HAM1_CBSV
pYES2 GAL+ pYES2_HAM1_Sc GAL+ pYES2_HAM1_CBSV GAL+
10-1 10-2 10-3 10-4
59 
 
but the results do provide evidence to suggest that the expression of the HAM1 genes from yeast and 
CBSV can confer increased resistance to the toxic effects of the pyrimidine analogue.  
 
Figure 3.16. Bar chart showing the average growth scores (n=2) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids across all serial dilutions at a 5-fluorouracil concentration of 
10μg/ml, with and without supplemented galactose. 
At the 10-2 cell dilution at a concentration of 40μg/ml 5-FU, the same result was seen upon the addition 
of galactose as was observed at the 10-2 cell dilution with 5-FU at 10μg/ml (Fig. 3.17), yet the increase 
in growth score observed for the pYES2_HAM1_Sc transformed cells was significant (p < 0.001). 
Otherwise, at the other serial dilutions at this 5-FU concentration, the growth scores of the 
pYES2_HAM1_CBSV transformed cells increase when the CBSV HAM1 is being expressed, but these 
results are not conclusive that the CBSV HAM1 complements the function of the yeast HAM1 due to 
no readily apparent differences to the pYES2 transformed cells and due to the fact that the increases 
in growth scores are not significant (p = 0.3, p = 0.423). At the 10-1 cell dilution, this increase in the 
growth scores of the pYES2_HAM1_CBSV transformed cells (p = 0.423) was also reflected in those cells 
transformed with the empty pYES2 vector upon addition of galactose (p < 0.001), thus, at this dilution, 
there seems to be no apparent effect on the ability of the ham1 knockout cells to display resistance 
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Figure 3.17. Bar chart showing the average growth scores (n=2) of the ham1 knockout S. cerevisiae cells transformed with 
the pYES2, pYES2_HAM1_Sc and pYES2_HAM1_CBSV plasmids across all serial dilutions at a 5-fluorouracil concentration of 
40μg/ml, with and without supplemented galactose. 
At a 5-FU concentration of 60μg/ml, the addition of galactose did little to affect the growth of the 
cells; with the only increase in growth observed for the pYES2_HAM1_Sc transformed cells at the 10-
4 cell dilution (p < 0.001). Similarly, at the highest concentration of 5-FU tested (80μg/ml), there was 
no increased resistance to the pyrimidine analogue brought about through the expression of the yeast 
or CBSV HAM1 genes. At this greatest concentration of 5-FU, it might be too concentrated for the 
function of HAM1 alone to afford increased protection to the effects of the molecule.  
Thus, the only effect seen on resistance to 5-FU through the expression of the yeast or CBSV HAM1 
genes was at two cell dilution concentrations at the lowest 5-FU concentration. These results alone 
are not enough to confirm whether the CBSV HAM1 can complement the yeast ham1 mutant, or 
whether the viral HAM1h shares functionality with the yeast HAM1.  
3.8 BROMODEOXYURIDINE, 5-FLUCYTOSINE AND 6-AZAURACIL RESISTANCE ASSAYS 
Similar plate-based assays were attempted with other base analogues such as bromodeoxyuridine, 5-
flucytosine and 6-azauracil, however, these inhibitors proved to be far more mutagenic than 5-FU. 
Despite evaluating a range of concentrations of inhibitor and yeast cell dilution, no clear pattern of 
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CHAPTER 4 – INVESTIGATING THE TRANSCRIPT 
LEVELS OF THE NICOTIANA BENTHAMIANA 
HAM1 WHEN INFECTED WITH CASSAVA 




As with bacteria, fungi and animals, plants also appear to have HAM1 proteins that along with other 
eukaryotic HAM1 proteins, function in the nucleus of the cells, yet their NTPase activity has yet to be 
fully investigated. In Arabidopsis thaliana, there are several HAM-like proteins that primarily function 
as histone acetyltransferases (HATs) and regulate gene expression to control such things as cell 
determination, flowering times and the formation of gametophytes (Earley et al., 2007; Latrasse et 
al., 2008; Xiao et al., 2013; Zhou et al., 2015). These HAM proteins belong to the Maf family, which 
show NTPase activity, and their overexpression is shown to inhibit cell division through the arrest of 
septum formation, likely as a result of their action on non-canonical nucleotides which lowers the 
concentrations of GTP and ATP (Galperin et al., 2006). As these plant proteins appear to exhibit NTPase 
activity alongside their primary function, they may provide an as yet unrecognised plant defense 
mechanism with the ability to protect against mutation inducing oxidative stress when the plant is 
infected. The potential that the plant could down regulate its HAM1 and thus provide a highly 
mutagenic environment for the pathogen within its cells, was the hypothesis behind this novel 
investigation. Studies looking into the effect of CBSV infection on the expression of the cassava HAM1 
have not been conducted, nor has any such investigation been carried out on model host plant species. 
It was thought, therefore, that by investigating the effects of CBSV infection on the plant HAM1, 
whether the gene is up or down regulated as a result, may provide further elucidation into the function 
of the CBSV HAM1h.  
With the time constraints and the lengthy life cycle of the cassava plant, it was not possible to carry 
out the investigation within the CBSV natural host species. Due to its ability as a systemic host for 
CBSV infection (Monger et al., 2001b) and its susceptibility to many plant viruses (Ogwok et al., 2010), 
however, Nicotiana benthamiana plants were used in this study. In order to measure the effect that 
infection with CBSV had on the expression of the plant HAM1, changes in the plant HAM1 transcript 
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levels from four different parts of the plant would be compared to those of a reference gene, known 
as a housekeeping gene, that is expressed constitutively. These results would also be compared to the 
transcript levels of the housekeeping and HAM1 genes in healthy N. benthamiana plants and ones 
infected with Tobacco mosaic virus (TMV). The four parts of the plant tested would be the shoot tip, 
stem, mature leaves and young leaves. It was further proposed that the HAM1 transcript levels in each 
part of the plant would show differences; with the shoot tip and young leaves being areas of rapid cell 
division and thus, should present greater HAM1 transcript levels when healthy, with the effect of CBSV 
and TMV infection being unknown. Quantitative PCR (qPCR) is the most common method for 
determining gene expression patterns and comparing gene transcript levels due to its high specificity 
which provides accurate, sensitive and reproduceable results (Liu et al., 2012). qPCR works through 
the use of fluorescent dyes that bind to the synthesised dsDNA with the number of cycles required to 
produce a detectable amount above the cycle threshold (Ct) level, recorded. The Ct values obtained 
for the gene of interest, in this case HAM1, and the housekeeping gene, are compared and the analysis 
of these results determines if the gene of interest has been up or down regulated through an increase 
or decrease in transcript levels, respectively.   
There are four HAM-like genes (HAM1-HAM4) found in A. thaliana. Deletion of the A. thaliana HAM1 
amino acids 117 through to 230, showed that it then prevented the protein’s ability to interact with 
the WUSCHEL (WUS) protein that is required for the control of stem cell populations in the shoot 
apical meristem (SAM). This revealed that the N-terminal of the HAM1 protein is essential for its 
function, and it was shown that this region is highly conserved amongst the A. thaliana HAM proteins 
and in other plants (Zhou et al., 2015). Discovery of the HAM1 protein in N. benthamiana, however, 
required bioinformatic analysis in order to design primers for use in this investigation.   
4.2 BIOINFORMATIC ANALYSIS 
A Basic Local Alignment Search Tool (BLAST) search using the NCBI database of the yeast HAM1 protein 
sequence revealed 40% identity to a sequence in N. benthamiana. No described sequences for this 
HAM1 protein in N. benthamiana are currently described in the NCBI database, and so the yeast HAM1 
sequence was used in a BLAST search in the Sol Genomics Network database against the N. 
benthamiana genome. Results of this search found the same sequence in N. benthamiana; a protein 
of length 227 amino acids was identified as a ‘non-canonical purine NTP pyrophosphatase (ITPase-
like)’ (Appendix Fig. 1). Further BLAST searches of this N. benthamiana HAM1 in the Sol Genomics 
Network found two other proteins within the N. benthamiana genome with 96% and 66% sequence 
identity and they were identified as the ‘inosine triphosphate pyrophosphatase-like’ protein and the 
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‘non-canonical purine NTP pyrophosphatase’, respectively, highlighting that three apparent HAM1 
proteins are found within the N. benthamiana genome.    
The N. benthamiana HAM1 sequence that showed greatest homology with the yeast HAM1 (40% 
sequence identity) was then used in a BLAST protein search in the NCBI databases and revealed 
approximately 49% and 50% sequence identity with the UCBSV and CBSV HAM1h proteins 
respectively. All four HAM1h protein sequences analysed contained the highly conserved SHR motif 
(Fig. 4.1).  
Figure 4.1. Results of the BLAST search and alignment showing sequence identity, highlighted in red, between the N. 
benthamiana HAM1 (Query_10001), S. cerevisiae HAM1 (Query_10002), CBSV HAM1h (Query_10003) and UCBSV HAM1h 
(Query_10004). All have the conserved SHR motif that is found in all HAM1 homologues. 
4.3 PRIMER DESIGN 
Further analysis on the Sol Genomics Network database of this BLAST search revealed that the 
genomic DNA sequence of the N. benthamiana HAM1 is 6,987 base pairs long. Comparisons of the 
DNA sequence with the amino acid sequence (Appendix Fig. 2) allowed for the identification of the 
exons which were subsequently used for the design of the primers (Appendix Fig. 3). qPCR Primers 
were required to be designed for the N. benthamiana HAM1 such that the size of the product would 
be of a similar size to the housekeeping gene product, and that the conditions would be appropriate 
to amplify both the N. benthamiana HAM1 and the housekeeping genes. One limiting factor to the 
technique is the selection of a suitable housekeeping reference gene. This reference gene must be 
stably expressed within the tissues being tested regardless of any treatments applied. As these 
housekeeping genes provide the point of reference to which the target gene is compared, selection 
of an unsuitable reference gene can lead to the results being interpreted incorrectly (Liu et al., 2012). 
Protein phosphatase 2A (PP2A) was identified as a suitable housekeeping gene for use in the qPCR 
experiment due to its stability in virus-infected N. benthamiana tissue (Liu et al., 2012). Primers 
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designed to this PP2A gene amplified a product of 123 base pairs under PCR conditions of between 50 
and 55oC (Table 4.1). The nucleotide sequence of the N. benthamiana HAM1 gene was entered into 
the GenScript website and primer pairs were designed in view of the conditions required for 
amplification and the size of the housekeeping gene product. Two primer pairs were designed; the 
first pair generated a PCR product of 124 base pairs and was named HAM11, and the second pair 
generated a PCR product of 126 base pairs and was named HAM12 (Table 4.1). Subsequent testing of 
the two HAM1 primer pairs and the PP2A primer pair using PCR analysis was carried out to establish 
the optimum conditions for both. Furthermore, to ensure the N. benthamiana HAM1 primers selected 
were only going to amplify the N. benthamiana HAM1 gene and not the viral HAM1 gene in the CBSV 
infected plants, the HAM11 and HAM12 sequences were compared to those of a primer pair designed 
to amplify the CBSV HAM1 gene, CBSVHAM1 (Table 4.1). Comparisons of the primer sequences 
revealed some similarities between the pairs, with the HAM12 forward primer sharing some 66% 
sequence identity to the CBSVHAM1 equivalent. Most importantly, however, it is the bases at the 3’ 
end of primer sequences that confer specificity to the target gene and mismatches of even one or two 
bases can drastically reduce primer efficiency (Whiley and Sloots, 2005). Despite the similarities in the 
primer sequences, there are few similarities at the 3’ end and thus, this ensures that the N. 
benthamiana HAM1 primer pairs are indeed specific only to the plant HAM1 gene.  
Table 4.1. List of primer pair sequences for the N. benthamiana HAM1 gene, the CBSV HAM1 gene and the three N. 
benthamiana housekeeping genes: PP2A, F-BOX and GBP.  
Primer pair Gene accession number Primer sequences (5’-3’) forward/reverse 
PP2A TC21939 (At1g13320) GACCCTGATGTTGATGTTCGCT/GAGGGATTTGAAGAGAGATTTC 
HAM11 Niben101Scf18106g00001.1 AAGGGTCTCCCAGGTACTCA/TGTTGAGGCCTTCATGACCA 
HAM12 Niben101Scf18106g00001.1 GCCAGAACTTCAAGGTGAGC/GGGAGACCCTTAAGAGCGTT 




GBP TC20872 (At5g59840) GGAACTGGATTCGCAACATAGA/GACCCTTGGAAGTTGGCACAGC 
 
4.4 PRIMER OPTIMISATION 
Healthy and CBSV infected N. benthamiana were grown before tissue samples were collected, RNA 
extracted and cDNA synthesised, to test the primers for the target and housekeeping genes. The two 
primer pairs for the N. benthamiana HAM1 were tested through PCR, with the second pair (HAM12) 
proving to produce greater amplification of the gene. For all subsequent PCR and qPCR reactions, this 
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HAM12 primer pair was used. Initially, the housekeeping gene PP2A was proposed to be used in the 
experiments, however, on use in PCR, this gene did not perform well at the suggested annealing 
temperature of 55oC (Fig. 4.2) and thus, amplification of the PP2A housekeeping gene was deemed 
not to be strong enough for use in qPCR. Reduction of the annealing temperature to 52oC saw 
amplification of HAM1 increase, but again, amplification of PP2A was too low (Fig. 4.3).  
 
Figure 4.2. Gel electrophoresis showing amplification of the PP2A gene in lanes 1-4 and of the HAM1 gene in lanes 6-9 
extracted from healthy N. benthamiana tissue following PCR with an annealing temperature of 55oC. 
 
Figure 4.3. Gel electrophoresis showing amplification of the PP2A gene in lanes 1-8 and of the HAM1 gene in lanes 10-17 
taken from healthy and CBSV infected N. benthamiana tissue following PCR with an annealing temperature of 52oC. It is 
shown here that the reduction in annealing temperature allowed for greater amplification of the HAM1 gene but did not 
produce sufficient amounts of the PP2A gene for use in qPCR. 
Instead, primers for a further second and third N. benthamiana housekeeping genes which also 
showed stability in CBSV infected tissue, the GTP binding protein (GBP) and F-box protein (F-BOX), 
were used (Table 4.1) (Liu et al., 2012). In order to achieve sufficient amplification of a housekeeping 
gene, primers for the GBP and F-BOX genes were used in PCR. Initial PCR procedures carried out at a 
temperature of 55oC proved too high for sufficient GBP and F-BOX amplification (Fig. 4.4), although 
amplification was higher for the GBP gene at this annealing temperature compared to that of the other 
housekeeping gene F-BOX. Reduction of the annealing temperature, again to 52oC, provided the ideal 
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conditions for sufficient amplification of GBP (Fig. 4.5), and so this housekeeping gene was selected 
for use in qPCR with the HAM12 primers with the annealing temperature set to 52oC.  
 
Figure 4.4. Gel electrophoresis showing the amplification of the GBP housekeeping gene in lanes 1-4 and of the F-BOX 
housekeeping gene in lanes 6-9, following PCR with an annealing temperature of 55oC. GBP showed greater amplification 
than the F-BOX housekeeping gene, so GBP was selected for further optimisation tests to find the annealing temperature 
to produce sufficient levels of amplification for use in qPCR. 
 
Figure 4.5. Gel electrophoresis showing the amplification of the GBP housekeeping gene in lanes 1-4 and of the F-BOX gene 
in lanes 7-10, following PCR with an annealing temperature of 52oC. Sufficient amplification of GBP was produced for use in 
qPCR. 
4.5 QUANTITATIVE PCR (QPCR) 
Healthy N. benthamiana plants were grown in the same conditions (16h/8h light/dark cycle at 25oC 
and watered when required) as those infected with CBSV via agroinfiltration with the CBSV Tanza 
infectious clone, or with TMV via sap inoculation. Symptoms of CBSV were observed at fourteen days 
post-inoculation (Fig. 4.6). Tissue samples were collected from the shoot tips, stems, mature leaves 
and young leaves of the healthy and virus-infected plants eighteen days post-inoculation. RNA was 
extracted from the tissue samples using the TriZol protocol, before complementary (c)DNA was 
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produced using first-strand cDNA synthesis following DNase treatment of the extracted RNA. PCR was 
then carried out on the cDNA produced from the CBSV infected plant tissue to confirm the presence 
of the virus (Fig. 4.7).  
 
 
Figure 4.6. Symptoms of CBSV observed on N. benthamiana plant (A) and N. benthamiana leaf (B) fourteen days post 
inoculation. 
 
Figure 4.7. Confirmation of viral infection by reverse-transcription PCR (RT-PCR) using primer pairs for section 1 (1kbp) of 
the CBSV infectious clone, with samples from the shoot tip (1), stem (2), mature leaves (3) and young leaves (4). Variations 
in band strength were due to the amount of cDNA synthesised from each RNA sample which were not adjusted before use 
in the PCR. The CBSV infectious clone (5) band, used as a control, is much brighter as the sample was at a much higher 
concentration. 
Following confirmation that the plants were infected with CBSV, qPCR could then be carried out. The 
concentration of the cDNA synthesised from the purified RNA for each sample was determined by 
nanodrop and adjusted through dilution, so all samples contained 500ng cDNA. The cDNA from the 
A B 
1 2 4 5 3 
68 
 
healthy, CBSV infected and TMV infected samples were then used in the qPCR procedure with the 
HAM1 and GBP primer pairs and SYBR Green I fluorescent dye. The end-point qPCR products were 
then run on an agarose gel to check the size of the fragments produced to ensure the correct genes 
were amplified (Fig. 4.8).  
Figure 4.8. Gel electrophoresis of the qPCR products with the GBP fragments (A) and the HAM1 fragments (B). Controls 
containing nuclease-free water are in the last two lanes (from left-to right) of each gel. The bands of the qPCR products in 
each lane were below the 200bp band on the hyperladder as the fragment sizes produced for the GBP and HAM1 genes 
were approximately 120bp long. 
The qPCR result output is an amplification plot which shows the Ct values of each sample. These Ct 
values were used in 2-ΔΔCt analysis to establish the relative expression of the HAM1 transcript levels in 
the different parts of the healthy, CBSV infected or TMV infected plant compared to the housekeeping 







Figure 4.9. Bar chart showing the relative expression of the N. benthamiana HAM1 transcript levels compared to that of 
the housekeeping gene GBP, in different parts of the plant when healthy, infected with CBSV or infected with TMV (n=1). 
No value was obtained from the qPCR for the shoot tip sample of the TMV infected N. benthamiana plants. 
Following the analysis of the Ct values, it is observed that the HAM1 transcript levels are relatively low 
in all parts of a healthy N. benthamiana plant. However, in areas where rapid cell division occurs, such 
as in the shoot tip and young leaves, there seems to be no apparent increase in HAM1 expression. 
There are significantly higher levels of expression of the N. benthamiana HAM1 in the shoot tip of the 
CBSV infected plant compared to the HAM1 transcript levels in the shoot tip of a healthy plant. 
Whether this is a plant response specific to CBSV is not known as no result was obtained from the 
TMV infected N. benthamiana plants due to RNA degradation.   
The samples taken from the stems of healthy and TMV infected plants both show greater levels of 
HAM1 expression than stem samples from CBSV infected plants. For those CBSV infected plants, it 
could be that the infection has yet to induce an oxidative stress response from the plant in the stem, 
as perhaps the virus remains undetected in the phloem. Why the HAM1 transcript levels are lower 
than those in the healthy plant, however, remains to be explained.  
In both the mature and young leaf samples, the greatest HAM1 transcript levels are seen in the CBSV 
and TMV infected plants. It was expected that there would be higher N. benthamiana HAM1 transcript 














































and therefore would have produced greater levels of HAM1 to protect against the increase in non-
canonical nucleotides.  
As no prior work has been done on the transcript levels of the N. benthamiana HAM1 when infected 
with CBSV, it is important to highlight that this investigation was very much a pilot study to ascertain 
the possible effect that CBSV infection may have. Furthermore, due to time constraints, there were 





















CHAPTER 5 – DISCUSSION AND CONCLUSION 
 
CBSV is one of two viruses belonging to the Ipomovirus genus in the Potyviridae family to contain a 
HAM1h protein. Bioinformatic analysis has shown it shares some 33 amino acid residues that are 
highly conserved across all HAM1 homologues from a variety of organisms, from prokaryotes to 
eukaryotes, yet the precise function of the viral protein remains unknown (Mbanzibwa et al., 2009a; 
2011a). The aim of this thesis was to help establish what the function of the viral protein could be, 
with this being investigated in two ways; firstly, the functionality of the protein was tested in both 
wild type and ham1 mutant strains of S. cerevisiae, and secondly, the expression of the HAM1 gene in 
N. benthamiana was investigated to see what effect infection with CBSV would have.  
5.1 CBSV HAM1H FUNCTIONALITY IN YEAST 
Extensive work has been carried out on ITPase function in humans with respect to cancer biology and 
acquired resistance to chemotherapy drugs, with many studies being conducted using both E. coli and 
S. cerevisiae as model organisms and the functionality of their respective ITPases when exposed to 
mutagens (Carlsson et al., 2013). The ITPase family, in which HAM1 and its homologues can be found, 
represent a highly conserved superfamily of NTPases (Galperin et al., 2006) which act upon (d)ITP and 
(d)XTP to prevent the incorporation into replicating nucleic acids of hypoxanthine or xanthine 
respectively (Savchenko et al., 2007). ITPases thus perform a vital function to ensure high-fidelity 
genomic replication and furthermore, their importance is shown through their highly conserved 
functionality from bacteria and archaea, through to eukaryotes (Stepchenkova et al., 2009b).  
Studies have shown that the yeast HAM1 and its homologues in E. coli, Methanococcus jannaschii and 
in humans, are able to dephosphorylate the non-canonical purine and pyrimidine base analogues in 
the cellular nucleotide precursor pools, preventing their incorporation into the replicating DNA and 
RNA, and due to the high level of conservation, can compensate for mutant defects in each other 
(Kozmin et al., 1998; Hwang et al., 1999; Stepchenkova et al., 2009b). As the viral HAM1 protein 
sequence shares 33 conserved amino acid residues with the yeast HAM1 and its homologues 
(Mbanzibwa et al., 2009a; 2011a), it was hypothesised that the viral protein would also show similar 
protective activity. Spot assays were conducted with both wild type and ham1 mutant S. cerevisiae 
strains to establish if through overexpression of the viral HAM1 gene, a similar phenotype would be 
observed as those overexpressing the yeast HAM1, and whether through expression of the viral HAM1 
in the ham1 mutant strains, if the yeast HAM1 function can be complemented. Due to HAP being 
72 
 
unavailable, cycloheximide (CHX), methotrexate (MTX) and the pyrimidine base analogue, 5-
fluorouracil (5-FU), were used.  
Work carried out by Kozmin et al. (1998) showed that HAP-induced mutagenesis in E. coli, through the 
mispairing of HAP base pairs, is not recognised by the cell repair systems nor is it proof-read. This was 
also observed for HAP-induced mutagenesis in S. cerevisiae and highlights the need for cells to 
eliminate the mutagenic non-canonical nucleotides before their incorporation into the replicating 
DNA. Additionally, a double mutant in the E. coli HAM1 homologue, RdgB, elicits the formation of a 
lesion in the DNA that ultimately makes the cell inviable through degradation of the chromosome, and 
further corroborates the findings that RdgB functions to prevent the incorporation of these non-
canonical nucleotides into the replicating DNA (Clyman and Cunningham, 1987; Burgis et al., 2003). 
The HAM1 homologue of E. coli, RdgB, has been extensively studied. Findings by Savchenko et al. 
(2007) show it forms a homodimer containing 12 α-helices and 6 β-sheets, with a large cavity between 
the two protein lobes. Found within this cavity is the Serine-Histidine-Arginine (SHR) motif that is 
common to all HAM1 homologues and therefore suggests that this highly conserved sequence forms 
part of the active site of not only the E. coli HAM1 homologue, but of all ITPases (Savchenko et al., 
2007). Bioinformatic analysis (see section 4.2) of the HAM1 sequences from S. cerevisiae, CBSV and 
UCBSV, showed that they all contained this highly conserved SHR motif, providing further evidence to 
suggest that the viral HAM1h proteins could also display nucleoside pyrophosphatase activity.  
These prior studies have mostly used 6-N-hydroxylaminopurine (HAP), a purine analogue (Carlsson et 
al., 2018), as it is a potent mutagen for both prokaryotic and eukaryotic organisms and thus has 
allowed for the extensive study of mutant phenotypes in both E. coli and S. cerevisiae. Most notably, 
S. cerevisiae ham1 mutant strains demonstrate hypersensitivity to this potent mutagen, yet studies 
have shown the HAM1 function can be complemented (Noskov et al., 1996; Kozmin et al., 1998). Work 
by Kozmin et al. (1998) showed that the HAM1 protein does not function in the repair of DNA but 
rather has enzymatic activity that breaks down the non-canonical nucleotides into their constituent 
monophosphates. This was later supported in the findings by Carlsson et al. (2018) that suggested the 
HAM1 protein does have pyrophosphatase activity. It was first thought that the HAM1 protein only 
provided specific resistance to HAP (Pavlov, 1986), yet further studies have shown it also confers 
resistance to several pyrimidine analogues, including 6-azauracil and 5-bromodeoxyuridine (Takayama 
et al., 2007; Carlsson et al., 2013), as well as exhibiting weaker resistance to the folate analogue 
metabolic inhibitor, MTX (Carlsson et al., 2013). In the current study, however, no such evidence of 
protective activity towards MTX was displayed in the phenotypes of yeast cells expressing or 
overexpressing either the yeast or CBSV HAM1 genes. It is thought, therefore, that perhaps the GAL 
induced overexpression of the HAM1 gene was too much of a burden on the cells and thus did not 
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confer any increased resistance, or indeed that the phenotype is very condition-dependent and 
suitable growth conditions were not created in these assays. Growth of ham1 mutant yeast expressing 
the yeast HAM1 gene was not always observed at some cell dilutions, particularly at 60μg/ml MTX 
concentration, thus comparisons with the activity of the viral HAM1h could not be made but does 
suggest that the CBSV HAM1h can provide a similar level of resistance to MTX as the yeast HAM1, as 
was seen at other MTX concentrations at the same cell serial dilutions. More assays would need to be 
conducted, however, to reliably ascertain the phenotypic responses.   
As HAP is a nucleotide analogue, it thus provides a direct assay to investigate the function of the HAM1 
protein and HAM1 homologues. Due to its toxicity, however, HAP is no longer commercially available 
and as a consequence of it not being available for use in this investigation, there were constraints in 
the chemicals that could be used to test the HAM1 function. Like HAP, 5-FU is a ‘pure’ base analogue 
that only induces mutagenesis through its misincorporation into the replicating nucleic acid and 
causes further damage through the subsequent repair mechanisms to remove these mismatched 
bases. These ‘pure’ nucleotide analogues do not damage other cellular components and their lethal 
effects can be attributed to mutations in specific vital genes (Pavlov et al., 1991), thus providing a 
direct assay for the testing of the mutant strains.  
Surprisingly, however, no effect was seen on either the overexpression of the yeast or CBSV HAM1 
genes on the resistance to 5-FU. There was, however, increases in growth observed for both the 
pYES2_HAM1_Sc and pYES2_HAM1_CBSV ham1 knockout S. cerevisiae transformed cells compared 
to the growth of cells not expressing any HAM1 at the two lowest concentrations of 5-FU, and thus 
suggests that expression of the CBSV HAM1 gene can provide a similar level of resistance to 5-FU as 
the yeast HAM1. At the higher concentrations, the expression of either HAM1 gene was possibly not 
sufficient to confer resistance to the pyrimidine analogue and suggests that these concentrations of 
5-FU were too high for use in the spot assays. A study by Carlsson et al. (2013) found that a deletion 
of the HAM1 gene had little effect on the yeast sensitivity to 5-FU and thus, the effects of the deletion 
would not be significantly observable in these spot assays. Furthermore, Carlsson et al. (2013) only 
produced significant results between the wild type and ham1 mutant strains when the yeast cells were 
forced to use the 5-FU as their uracil source, which was not the case in these spot assays. Taken 
together, these studies support at least in part, that the CBSV HAM1h is indeed a functional HAM1 as 
similar phenotypes are seen if overexpressing the yeast or CBSV HAM1. For a definitive outcome, more 
sensitive assays would need to be conducted, preferably using HAP as the mutagen as the HAM1 
deletion in yeast provides a hypersensitive phenotype that is clearly observed (Noskov et al., 1996).  
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The other mutagens studied, CHX and MTX, are not base analogues and thus do not provide a direct 
assay; instead, they target other cellular components and protein synthesis which subsequently 
causes imbalances in the nucleotide precursor pools (Longley et al., 2003; Alamgir et al., 2010; 
Buchanan et al., 2016). Their effect, therefore, is complex and indirect, with no one mutation in 
specific vital genes attributable to their toxic effects (Pavlov et al., 1991), thus making their 
phenotypes much harder to observe. The HAM1 protein, however, can still afford some protection 
against these molecules through their indirect action of causing oxidative stress within the cells which 
leads to the production of non-canonical nucleotides. Results from the CHX spot assay, moreover, 
show that the overexpression of both the yeast and CBSV HAM1 genes did confer greater resistance 
to the effects of CHX at the greatest cell serial dilutions at the CHX concentration of 45ng/ml, and 
more importantly, that the CBSV HAM1h appears to confer similar protective activity to CHX as the 
yeast HAM1; a result that was also observed at the 10-4 cell dilution at the CHX concentration of 
130ng/ml. The spot assays conducted to determine whether the HAM1 genes from CBSV and yeast 
can restore resistance to CHX revealed no apparent effect on their expression at the two lowest CHX 
concentrations studied. It might be that this concentration was too low for the slight phenotypic 
effects of the expression of the HAM1 genes to be observed. At the CHX concentration of 100ng/ml, 
however, at the two greatest cell serial dilutions, an effect due to the expression of both the yeast and 
CBSV HAM1 genes was noted and an increase in resistance to CHX was confirmed. Similarly, this result 
could be inferred at the 10-4 cell dilution at a concentration of 130ng/ml, though it could not be 
confirmed through the lack of results obtained for cells not expressing a HAM1 gene.  
Overall, results from the CHX spot assays suggest that the CBSV HAM1h is likely to show 
pyrophosphatase activity, replicating the function of the yeast HAM1 in conferring some increased 
resistance to CHX, however, further studies would need to be conducted on the effects of the viral 
HAM1 protein to a series of purine and pyrimidine analogues. In the future, these studies would 
preferably be carried out in an E. coli background as the prokaryotic cells are more sensitive to a 
broader range of nucleotide analogues (Kozmin et al., 1998). For this study, however, the E. coli strain 
with the correct mutation was not available.  
5.2 EFFECT OF CBSV INFECTION ON PLANT HAM1 TRANSCRIPT LEVELS 
Plants use a variety of mechanisms to defend themselves against pathogens, with most comprising 
preventative measures to inhibit the entry of pathogens. With viruses, however, plants are unable to 
deploy these mechanisms as their preventative defences have already been breached. Once the virus 
has become a part of the cell, the plant can only respond by inducing oxidative stress. This oxidative 
stress provides two vital roles in the plant’s fight against the pathogen; firstly, it elicits localised 
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necrosis of infected tissue and containment of the pathogen, and secondly, provides a diffusible signal 
to stimulate antioxidant and disease response genes (Demidchik, 2015; Hernández et al., 2016). These 
responses were first noted in the defence against bacterial and fungal pathogens but have also been 
observed in virus-infected plants. (Hernández et al., 2016).  
A result of this oxidative stress, however, is the accumulation of non-canonical nucleotides as 
canonicals bases in the precursor pools are damaged, and the likely subsequent increase in the rate 
of mutation through their misincorporation into synthesising DNA. It is therefore imperative that the 
plant produces its own NTPase, also known as HAM1, to protect itself from the incorporation of the 
non-canonical nucleotides if it is to overcome infection. Through expression of its own HAM1 gene 
when infected with viruses, however, the plant would simultaneously be providing protection to the 
virus and with the cycloheximide spot assays highlighting that the CBSV HAM1h does likely show 
pyrophosphatase activity, the question was posed why CBSV needs a HAM1 protein when the plant 
produces its own.  
It was therefore hypothesised that perhaps the plant downregulates its HAM1 when it is infected with 
a virus to create hostile conditions for the virus, with the increases in non-canonical nucleotides 
providing high rates of mutagenesis that may render the virus inviable and cause an extinction in the 
population (Mbanzibwa et al., 2009b). This hypothesis would provide a reason why CBSV has acquired 
and retained its own HAM1 gene. Alternatively, the plant may not downregulate its HAM1 when 
infected with CBSV in order to protect itself from those non-canonical DNA nucleotides that have 
arisen as a result of oxidative stress. The virus may then have acquired its own HAM1 as the plant 
ITPase may afford insufficient protection against the RNA non-canonical nucleotides that have formed 
in the precursor pools and that the virus will depend upon to replicate. Most eukaryotes NTPases act 
against DNA non-canonical bases and to a lesser extent on non-canonical RNA nucleotides, and thus 
the CBSV HAM1h may be specific to RNA non-canonical nucleotides. If this is the case, perhaps the 
virus requires the plant HAM1 in addition to its own to overcome the stresses of those non-canonical 
RNA bases.   
In order to establish whether the plant HAM1 is either downregulated or overexpressed upon 
infection with CBSV, quantitative PCR (qPCR) was carried out on N. benthamiana plants when infected 
with CBSV or Tobacco mosaic virus (TMV) and compared to healthy plants. N. benthamiana has been 
shown to be a suitable host for the study of the infection of CBSV (Bua and Namara, 2009; Ogwok et 
al., 2010), with plants showing severe symptoms leading to necrosis (Patil et al., 2015) across all parts 
of the plant which is unlike what is seen in cassava plants where the majority of foliar symptoms, if 
any, are only observed in the mature leaves (Mbanzibwa et al., 2009b; Abarshi et al., 2010).  
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Results of the qPCR investigation, following analysis, showed that the N. benthamiana HAM1 is clearly 
not being downregulated when infected with either CBSV or TMV. This is shown by the increases in N. 
benthamiana HAM1 transcript levels in the mature and young leaves when infected. The greater level 
of plant HAM1 expression in these parts of the plant will likely be in response to the oxidative stress 
that is being induced from the developing infection from both CBSV and TMV – shown through the 
yellowing of the leaves.  
A very large increase in the N. benthamiana HAM1 transcript levels was observed in the shoot tip of 
those plants infected with CBSV. Samples were collected from the plants eighteen days post-
inoculation, and with CBSV infection causing the shoot tip to become necrotic about fourteen days 
post-inoculation, this part of the plant would have been under lots of oxidative stress at the time. 
These high levels of oxidative stress would thus induce increased expression of the plant HAM1 to try 
and combat this increase in non-canonical nucleotide levels. It is unclear, however, if the same would 
have been seen for those N. benthamiana infected with TMV as no result was obtained for the shoot 
tip sample. As TMV does not cause necrosis to shoot tips, it could be that the HAM1 levels in the plants 
infected with TMV would show a similar level of HAM1 expression as the other tissues taken from the 
TMV infected plants. Yet, as no result was obtained for the shoot tip sample due to RNA degradation, 
further experiments will be required to determine if the increase in plant HAM1 expression is a result 
of only CBSV infection or indeed a generalised response for any viral infection. 
The decrease in N. benthamiana HAM1 transcript levels in the stems of those infected with CBSV are 
likely due to the low levels of oxidative stress occurring as the virus is yet to take hold in the stems. 
Similarly, the same level of HAM1 transcript was observed in N. benthamiana plants infected with 
TMV as in the healthy plants, and suggests that there was little, if any, response from the plant to 
induce oxidative stress in the stems. Therefore, the lack of oxidative stress meant that there was no 
need for increased HAM1 expression.  
Experiments for this investigation were only able to be carried out once due to time constraints, 
therefore, this was a pilot study looking into the effects CBSV infection may have on N. benthamiana 
HAM1 transcript levels. Overall, the results from this investigation suggest that as the N. benthamiana 
HAM1 expression is not downregulated upon infection with CBSV, the CBSV HAM1 could be 
functioning to afford protection for itself against non-canonical RNA nucleotides and ensure the virus 
is not subject to any detrimental mutations. As no study of the effect of viral infection on plant HAM1 
expression has been conducted before, these results present a foundation for further study into the 
interactions of the plant and viral HAM1 proteins, and indeed for the effect on cassava HAM1 
transcript levels. Cassava is a longer living plant than N. benthamiana and thus the effects of the viral 
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HAM1 may be more pronounced in the actual viral host. Interestingly, a similar result was found by 
Martelli et al. (2007) where the Blackberry virus Y exhibited an AlkB domain in its P1 proteinase that 
conferred repair mechanisms to methylation damage of nucleic acids, specifically RNA. Furthermore, 
as this virus infects perennial, woody plants, it was suggested that this RNA repair was advantageous 
in providing stability for the virus in longer-lived hosts and through changing environmental conditions 
(Martelli et al., 2007; Mbanzibwa et al., 2009b).  
5.3 CONCLUSION 
Evidence produced through this project supports the hypothesis that the CBSV HAM1h does show 
pyrophosphatase activity, just like its homologues. Upon infection in the plant, which induces high 
levels of oxidative stress in response to the CBSV infection, the virus is likely to experience high levels 
of mutagenesis as a result of the incorporation of the non-canonical nucleotides into its replicating 
RNA. This will cause high-infidelity genomic replication, and lead to the virus no longer being viable 
and eventually lead to extinction for the virus population (Mbanzibwa et al., 2009b). Therefore, as 
with other organisms containing a HAM1, it is imperative for the virus to be able to combat the high 
levels of non-canonical nucleotides and prevent their incorporation into its replicating RNA. The 
results of the effect of CBSV infection on the plant HAM1 transcript levels, shows that the viral HAM1h 
is likely to target non-canonical RNA nucleotides.  
With the advances being made in generating full-length infectious clones of CBSV, the ability to cause 
specific mutations within viral genes will enable further investigations to take place looking into the 
function of the CBSV HAM1h. In the future, the targeting of this gene could provide a new source of 
CBSD resistance through the use of RNAi mechanisms, or through the mutation of this gene such that 
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Figure 1. BLAST protein search of the yeast HAM1 revealed 40% sequence identity with the N. benthamiana protein, ‘non-
canonical purine NTP pyrophosphatase (ITPase-like)’. 
 
>Niben101Scf18106g00001.1 sp|Q8TV07|NTPA_METKA ***- Non-canonical purine NTP 
pyrophosphatase IPR029001 (Inosine triphosphate pyrophosphatase-like) GO:0009143 
(nucleoside triphosphate catabolic process), GO:0016787 (hydrolase activity), 





Figure 2. The amino acid sequence of the N. benthamiana HAM1. 
 






































































































Figure 3. Genomic DNA sequence of the N. benthamiana HAM1 with exons highlighted and the stop codon underlined and 
highlighted in red. 
 
 
